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ABSTRACT
Splenic marginal zones are architecturally organized to generate a rapid response
against blood- borne antigens entering the spleen. The marginal zone is a distinct
anatomical micro-environment whose main components include the marginal zone
macrophages, the marginal zone B cells, the marginal zone sinus, and the metallophilic
macrophages. Marginal zone macrophages, in partnership with marginal zone B cells, are
particularly important in host defense against T-independent pathogens and are crucial
for the prevention of diseases such as Streptococcus pneumonia. It has been widely
reported that with the advancement of age there is a higher rate of mortality as a result of
bacterial pneumonia when compared to the young. My objective here was to determine if
there are age related changes in the cellular components of the marginal zone in old
versus young mice. Gross architectural changes in the marginal zones of old mice when
compared to young mice were found and that disruptions were observed among the many
components of the marginal zone, including: marginal zone macrophages, marginal zone
B cells, the marginal zone sinus lining cells, and the metallophilic macrophages. The
reduction in marginal zone macrophages in individual old mice also statistically
correlated with reduced frequency of marginal zone B cells. These findings further
strengthen a partnership of marginal zone macrophages and marginal zone B cells.
Furthermore, the phagocytic properties of marginal zone macrophages were examined
live on a per cell basis and no differences in phagocytosis of old marginal zone
xiv

macrophages when compared to young were found, demonstrating that it is this reduction
in the marginal zone macrophage population that contributes to the decline in the Tindependent immune response reported with age. Results obtained from these studies can
provide insight for the proper response needed to clear pathogens that have been shown
to be detrimental in the old.
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CHAPTER I
STATEMENT OF THE PROBLEM
More than 12.9 % of the U.S. population is over the age of 65 (1) and life
expectancy continues to make rapid gains as a result of advancements in modern
healthcare. However, older people suffer greater risks of long-term complications and
are still more susceptible to diseases than young and middle-aged individuals because of
the effects of a weakened immune system. One of the leading causes of death in persons
65 years and older is invasive pneumococcal disease (2, 3). Vaccines for the prevention
of invasive pneumococcal disease show a decline in immune protection in the elderly
when compared to the young (4, 5). This is possibly due to the reduced ability of the aged
immune system to deal with bacteria load and mount an immune response to the Tindependent (TI) antigen components that make up the vaccine. Therefore, understanding
how the immune system changes with age is critical for implementing better therapies
and vaccines for the prevention of age related disease.
Blood-borne antigens enter the spleen prior to circulating to other immune organs
(6). Blood-borne bacteria, viruses, parasites and other antigens enter a
compartmentalized area of the spleen, the marginal zone (MZ), where they are
sequestered by marginal zone macrophages (MZM) and marginal zone B cells (MZ B)
[reviewed in (7, 8)]. MZM are highly phagocytic cells and are responsible for rapid
1

2
clearance of blood-borne TI antigens and debris (7-9). MZ B cells are also well known
for their ability to respond to TI antigens by rapidly generating an IgM specific antibody
response (10)[reviewed in (11, 12)]. It is believed that the pathogen degradation products
shed by MZM are taken up by MZ B cells (8). Notably, the antigen components of
vaccines important for the prevention of bacterial pneumonia are TI (13). Thus,
examining the MZ compartment, especially MZM and MZ B cells, in the old may
provide an explanation for the increased susceptibility and decreased efficacy of vaccines
for bacterial diseases in the elderly.
MZM are capable of binding TI antigens through specific cell surface receptors.
Two important MZM cell surface receptors are: Macrophage Receptor with Collagenous
structure (MARCO) and Specific Intracellular adhesion molecule-Grabbing Nonintegrin
Receptor 1 (SIGN-R1) [reviewed in (7)]. MARCO binds to Staphylococcus aureus (14,
15) and Escherichia coli [reviewed in (15)]; SIGN-R1 [homologue of human DC-SIGN
(16)] binds the capsular polysaccharide of Streptococcus pneumoniae and also to the
polysaccharide dextran (17-20). Once MZM bind an antigen, they will introduce it to
closely associated MZ B cells (21). MZM and MZ B cells have a direct intercellular
interaction via the scavenger receptor, MARCO, expressed on MZM with an
undetermined ligand on MZ B cells (22-24). MZM and MZ B cells are positioned around
the outer border of the MZ sinus, facing the red pulp of the spleen (7). Positioned around
the inner border of the MZ sinus are the metallophilic macrophages (MMM), which face
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the white pulp of the spleen (7). The anatomical micro-architecture of the MZ can be seen
as critical for the proper binding and clearance of blood-borne pathogens.
Previous studies of the lymphoid architecture of old mice focused on disruption of
the white pulp areas, T cell-rich periarteriolar lymphoid sheath (PALS) and B cell
follicles, when compared to young mice (25-29). My initial observations of the splenic
tissue of most old mice suggested an overall alteration in the micro-architecture of the
MZ. Little is known about changes in the structure and cellular components of the MZ
with age, my investigation proposes that there is an alteration in the cellular
components that make up the MZ, specifically the MZM and MZ B cells, in old mice
when compared to young mice. This cellular alteration may impinge on the
functional ability to capture and phagocytize blood-borne antigen. Results of my
studies revealed decreased frequencies of MZM and MZ B cells and disruptions in
positioning of the mucosal adhesion cell adhesion molecule (MAdCAM-1+) sinus-lining
cells and MMM. The consequence of altered MZM in old mice was reflected by
reduction in binding of blood-borne dextran particles by the MZM. One explanation for
the decreases in MZM and MZ B cells observed with age could be due to alterations in
the aged microenvironment. The factors important for MZM and MZ B cell homing to
the MZ were examined. In individual animals decreases in MZM in old mice were found
to be correlated with decreases in MZ B cells. The chemokine CCL21 and its receptor
CCR7, chemotactic factors important for MZM homing were also found to be reduced in
old mice when compared to young mice. In cell transfer experiments, mature B cells
isolated from young recipient mice had ~50% fewer young donor MZ B cells in old
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spleens when compared to young spleens. Lastly, the function of MZM was examined
using a novel approach to measure MZM phagocytosis to determine if there were cellintrinsic alterations in age. On average, the phagocytic function of individual MZM
isolated from old mice was found to be unaffected upon administration of S. aureus
bioparticles, suggesting that a decrease in the MZM compartment rather than cellintrinsic defects in age is the primary factor for the decreased immune response to TI
antigens reported with age.
In this thesis, I will first provide a comprehensive review of the components that
make up the MZ. The MZM and MZ B cells will be emphasized as these cells are crucial
for the efficient clearance of TI antigens. The origin of MZM and the receptors expressed
on its surface will be discussed as well as a general overview of phagocytosis. MZ B cell
development in young adults will be reviewed and compared to MZ B cell development
in old mice. The MZ sinus as well as the MMM will also briefly be discussed. The
reminder of the literature review will discuss a survey of the relevant alterations in
immunity with age. The chapter following the literature review will give a complete
description of the experimental approaches performed followed by the results (divided
into 3 separate chapters). Lastly, I will discuss the significance of my findings and the
possible therapies for elderly patients to mount effective immune responses to lifethreatening pathogens such as S. pneumoniae.

CHAPTER II
LITERATURE REVIEW
Overview of the micro-architecture of the spleen
The spleen houses many of the cells important for an efficient immune response.
Histological examination of the spleen reveals a red pulp region and a white pulp region
(Fig 1). The red pulp is traditionally known as the region where red blood cells are
degraded by the red pulp macrophages that reside in the cords of the red pulp (30). The
white pulp is organized into specific zones (Fig. 1): a T cell zone [(periarteriolar
lymphoid sheath (PALS)], a B cell zone (follicle), and a marginal zone (MZ). The T cell
zone contains T cells that interact with dendritic cells (DC), stromal cells and B cells that
pass through. The B cell zone contains the follicular (FO) B cells, follicular dendritic
cells (FDC), and stromal cells. FDC and stromal cells secrete the chemokine CXCL13,
which is necessary for the FO B cells to home to this zone (31). FO B cells, unlike MZ B
cells, require interaction with T cells to mount an effective antibody response. Once
activated by T cells, FO B cells undergo immunoglobulin isotype switching, somatic
hypermutation, and clonal expansion (11, 32), which can be observed in H&E splenic
tissue sections as dark heavily nucleated areas known as germinal centers. The MZ is
made up of several components including: the MZM, MZ B cells, MMM, the MZ sinus,
natural killer (NK) cells, and DC (7, 8, 30). MZM form the outer ring of the MZ and
5
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interact with the MZ B cells. The DCs are also observed to be localized near the MZM
and MZ B cells. MMM form the inner ring of the MZ and are found facing the white
pulp of the spleen and are found to be in line with the MZ sinus.
A hallmark feature of the spleen is that it is the site where blood-borne antigens
are first detected by cells of the immune system (6). Antigens and recirculating
lymphocytes enter the spleen at the MZ. Recirculating lymphocytes enter the MZ from
the bloodstream similar to the process by which leukocytes transverse inflamed
endothelium (33). Once lymphocytes have re-entered the spleen each cell will position to
its corresponding zone as a result of chemotactic signals (31, 34, 35). Antigens will filter
through the porous MZ sinus (36) and depending on the nature of the antigens, will
initiate an immune response. Traditional FO B cells are activated by thymus-dependent
(TD) antigens and MZ B cells are activated by thymus-independent (TI) antigens (37,
38). TD antigens consist of soluble proteins and peptides that associate with MHC
molecules on the surface of antigen presenting cells (APC). The APC in the context of
MHC class II molecules will then interact with the T cell receptor on the surface of T
cells. Activated T cells will recruit and have direct contact with B cells that will produce
an immunoglobulin specific antibody response. TI antigens are generally large in
molecular weight, have repeating antigenic epitopes, and are able to activate the
complement signaling pathway. TI antigens are not able to stimulate MHC molecules on
the surface of APC. Therefore, TI antigenic components are able to elicit an antibody
response in the absence of MHC class II restricted T cell help.
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MZ
RP
T cell
WP

FO B cell

Splenic
White Pulp
Central
Arteriole

Splenic
Red PulpMZ B cell

(MZ
B)

MMM
MZ sinus
MZM

(MZ
M)Marginal

T cell Zone
B cell Zone

Zone

Figure 1. Schematic representation of the splenic marginal zone
Top left image is an H&E cross section of a young mouse (10x magnification). The
spleen is organized into a red pulp (RP) region and numerous white pulp (WP) areas.
The boundary of the MZ is depicted by the white arrow. Bottom left is a cartoon
depiction of the spleen narrowing in on the cellular organization of the MZ. The white
pulp region is divided into specific zones: marginal zone, B cell zone, and T cell zone.
The MZ is comprised of different cell types. The most notable cell types are the MZM
and MZ B cells. MZM and MZ B cells are seen interacting throughout the MZ. The MZ
sinus-lining cells are capillary extensions of the central arteriole and are the site where
blood-borne pathogens first enter the spleen. The MMM are tangentially positioned next
to the marginal sinus-lining cells facing the white pulp region.
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MZM and MZ B cell interactions and their functional importance
In the context of TI antigen responses in the spleen, MZ B cells and MZM are
important players in initiating an efficient immune response. At normal basal levels in
mice, MZ B cells home to the MZ due to an interaction with MZM (22) (Fig. 2). MZ B
cells and MZM interact via the scavenger receptor, MARCO, on MZM with an
undetermined cell surface receptor/ligand on MZ B cells (15, 22-24). In vivo studies
where anti-MARCO antibody was injected intravenously (i.v.) into mice resulted in
disruption of MARCO and MZ B cell interactions with displacement of MZ B cells to the
white pulp area and MZM retained in the MZ (15). MZM-MZ B cell interactions are
important functionally because MHC class II molecules, which are necessary for antigen
presentation, are not expressed on MZM. Therefore, it has been postulated that upon
binding and phagocytosis of microbes, the pathogen degradation products shed by MZM
are taken up by MZ B cells (Fig. 2) (15, 17). This functional interaction between MZMMZ B cells is another avenue aiding in the clearance of foreign pathogens.
Studies involving depletion of either MZM or MZ B cells in young adult mice
report loss of the corresponding cell population as well as morphological disruptions of
the MZ (Table I) (21, 39-41). A report by Kraal et al. studying MZM kinetics in the
spleen observed that depletion of macrophages, including MZM, by in vivo liposome
treatment lead to a subsequent loss of the B cells in the MZ (39). Recovery of MZM
correlated with full restoration of the MZ B cell population of these mice. More recently,
studies using SIGN-R1-/- mice, which have reduced MZM, reported decreases in MZ B
cell numbers when compared to wild type mice (21). On the other hand, reports in
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which MZ B cells were initially depleted in young adult mice by overexpression of CD70
(a TNF family member), which leads to a gradual loss of the splenic B cell pool, reported
a subsequent gradual loss of the MZM pool (40). This same study also found that MZM
failed to develop in BCR-/- mice lacking B cells. Similar studies have also found that
CD19 (determined here to be important for MZ B cell differentiation) deficiency in B
cells leads to a loss in MZ B cells by a mechanism believed to inhibit differentiation from
precursor B cells to MZ B cells (41). This study reported that absence of MZ B cells
corresponded with absence of MZM. Furthermore, adoptive transfer experiments were
performed in which mature purified B cells from wild type mice were able to reconstitute
the MZM pool after 17 days.
Investigators have also found the functional importance of MZM-MZ B cell
interactions. Studies have found that upon infection with S. pneumoniae, SIGN-R1-/mice have a reduced ability to mount an IgM specific antibody response against the
phosphorylcholine (PC) epitope of S. pneumoniae when compared to wild type mice,
which show elevated anti-PC IgM levels upon infection (20, 21). Similar experiments
done in vitro where B cells derived from
SIGN-R1-/- mice showed reduced anti-PC IgM levels upon stimulation when compared to
B cells derived from wild type mice (21). It is therefore predicted in age that if either the
MZM or MZ B pool is decreased, this will have an impact on the other cell type.
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Table 1. Depletion of MZM or MZ B cells and the effects on the MZ compartment
Effect
Report
Liposome
depletion of
splenic
macrophages

MZM

MZ B cell

--

-+

CD70 Tg
Mice

--

--

BCR -/-

--

--

In vivo blocking
of MARCO

++

++

CD19 -/-

--

--

+

+

CD19 -/reconstituted
with purified B
cells

MZ
Morphology
MZM, MMM
absent

MZ B cell
Position
80%
reduced
in MZ

Reference

Rooijen et al., 1989

MZM, MZ B
cells, and
MAdCAM1+
cells absent
after 8 wks

Completely
absent after
8wks

Nolte et al., 2004

MZM, MZ B
cells, & MMM
absent

Completely
absent

Nolte et al., 2004

MZM Present

MZM, MZ B c
absent.
MMM &
MAdCAM1+
cells present
MZM (17d) &
MZ B cells
(7d)

White pulp
area

Completely
absent

MZ

Karlsson et al., 2004

You et al., 2010

You et al., 2010

Table 1. Depletion of MZM or MZ B cell populations and its effects on the MZ
compartment. Survey of experiments that depleted either MZM or MZ B cell
populations in the spleens of mice. Symbols correspond to lack (- -) or presence (+ +) of
MZM or MZ B cells in the spleen.
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2
TI antigen

1

MZ B
cell

SIGN-R1

MZM
MARCO

Antibodies

3
Red
Pulp

MZ

Pathogen
degradation
products

White Pulp
Follicle

Figure 2. Functional interaction of MZM and MZ B cells. MZM and MZ B cells are
components of the MZ of the spleen. MZM have a physical interaction with MZ B cells
via the scavenger receptor MARCO located on the surface of MZM. (1) MZ B cells
recognize TI antigens via the BCR and generate a rapid IgM antibody response. (2)
MZM bind TI antigens predominantly through the cell surface receptors SIGN-R1
(depicted above) and MARCO. The antigen will then be phagocytized by the MZM.
(3)When antigen has bound MZM it is believed that the pathogen degradation products
shed by MZM are taken up by MZ B cells.
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Marginal zone macrophages
MZM are a type of macrophage population in the MZ that appear as a band of
cells forming the outer ring of the MZ. MZM begin to populate the MZ about 10 days
post-birth in mice (42). MZM are derived from monocytes that home to the MZ as a
result of the chemokines CCL19 and CCL21 that are expressed by gp38+ stromal cells
known to be important for T cell homing to the PALS (43). The exact origin of MZM
has not been determined, but earlier studies examining macrophage kinetics in the spleen
found that after liposome-mediated elimination of MZM, MZM did not repopulate the
MZ until after 1 month (39). In this study upon liposome treatment, the red pulp
macrophages (RPM), MMM, and MZM were eliminated simultaneously 24 hr post
treatment. After 1 wk the RPM were found to repopulate, followed by the MMM in 2
wks, and finally MZM after one month (39). This sequence of repopulation suggested to
the authors that MZM development may be under the influence of other splenic
macrophage subtypes. Interestingly, in this same study an absence of B cells that reside
in the MZ was also observed and did not start to re-emerge until after 16 days (39).
Although this study shows that MZM can be generated, it is not clear if the MZM
established 10 days post birth survives throughout the lifetime of the animal or if MZM
are constantly replenished as is the case with other white blood cell populations.
MZM are known for their ability to be highly phagocytic and in fact have been
referred to as “real scavenger cells” (8). MZM express on their surfaces a variety of
pattern recognition receptors capable of inducing phagocytosis. Three main receptors
have been characterized: Scavenger receptor A (SR-A); MARCO, a member of the SR
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family of receptors; the C-type lectin SIGN-R1 (the mouse analog of the human
dendritic cell-specific intercellular adhesion molecule [ICAM-3 grabbing nonintegrin) (
DC-SIGN)] [reviewed in (8)].
Function of the MARCO receptor on MZM
The MARCO receptor is expressed constitutively on MZM and is a member of
the scavenger receptors (7). Scavenger receptors are traditionally known for binding a
wide range of ligands such as polyribonucleotides, lipopolysaccharides, and silica
particles (44). Studies in mice have shown that after ligand binding to MARCO, MZM
are observed to traffic to the red pulp and MZ B cells displaced to the white pulp areas
(15). To demonstrate this, investigators injected the bacterial pathogen, S. aureus (a
known ligand for the MARCO receptor) i.v. into mice (14). Within 30 min of injection,
S. aureus could be visualized exclusively on MZM (15). At 18h after injection S. aureus
positive MZM were found to migrate into the red pulp, and MZ B cells were found in the
white pulp follicles (15). The migratory ability of MZM has been attributed to a
downregulation in SH2-containing inosital-5-phosphatase 1 (SHIP) signaling upon
binding antigen – as deletion of SHIP leads to displacement of MZM to the red pulp (15).
Structurally, MARCO contains a long collagenous triple helix. The C-terminal
region of MARCO has approximately 100 amino acids and has been recognized as the
region where bacteria bind (45). Although the downstream signaling pathways of
MARCO have currently not been directly determined, over-expression of MARCO by
other cell types has been shown to activate Rac1 (46). Furthermore, it has also been
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observed that MARCO over-expression results in cell shape changes that result in the
formation of what is described as “large lamellipodia-like structures.” These cell shape
changes have also been shown to be accompanied by rearrangement in actin cytoskelton.
It is important to note that while MARCO has been shown to bind antigen, it is believed
that this process of antigen internalization occurs as a result of co-receptor involvement
by a process not yet identified (47).
Function of the SIGN-R1 receptor on MZM
SIGN-R1, another prominent receptor on the surface of MZM was identified as
the murine homologue to human DC-SIGN. DC-SIGN is a receptor found on the surface
of dendritic cells in humans and is capable of binding the HIV-1 envelope glycoprotein
(17). DC-SIGN is a C-type lectin (recognize carbohydrates) (7, 47) that binds to the
adhesion molecule ICAM-3/CD50 expressed on resting T cells and ultimately transmits
the virus to T cells (17). Notably, more recent studies have shown that DC-SIGN binds
the gram-positive bacterium S. pneumoniae (16). SIGN-R1 on MZM has also been
shown to bind the capsular polysaccharide of S. pneumoniae (19, 20) as well as the gramnegative bacteria such as Escherichia coli (48) and the polysaccharide dextran (18).
Upon dextran binding, the SIGN-R1 receptor and antigen will internalize and this antigen
receptor complex has been shown to localize to lysosomes (17). Briefly, K562 cells were
transfected with monoclonal SIGN-R1 and administered dextran-FITC for 45 min at 37ᵒ
C. Immunofluorescence microscopy revealed dextran-FITC internalized to the
lysosomes. It has also been shown that the SIGN-R1 receptor on MZM is capable of
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interacting with the toll-like receptor 4 (TLR4), initiating the production of
proinflammatory cytokines (48). Transfection of SIGN-R1 into macrophage-like
RAW264.7 cells resulted in enhanced TLR4 oligomerization. Immunoprecipitation
experiments also revealed a physical association between SIGN-R1 and TLR4 (48).
TLR4 is important for the production of a wide range of proinflammatory cytokines (4951), which are important for proper immune function by inducing costimulatory
molecules and other inflammatory mediators at the site of invasion (52).
The binding of S. pneumoniae to murine SIGN-R1
In humans, S. pneumoniae is transmitted from an infected individual through
direct contact with their respiratory secretions (53). An estimated 10% of healthy adults
are carriers of some serotype of S. pneumoniae, which are non-invasive and stay within
the nasopharynx. When S. pneumoniae enters lung tissue through passage from the
nasopharynx, it is referred to as invasive, leading to the development of pneumococcal
disease. How does S. pneumoniae, a bacterium known to infect lung tissue, enter the MZ
to bind the SIGN-R1 receptor? S. pneumoniae crosses lung tissue and enters the blood
using the host’s receptor for platelet-activating factor (PAF) (53). This receptor is known
for the recognition of the phosphorylcholine (PC) determinant of the ligand PAF and is
expressed on a wide variety of cells including but not limited to platelets, monocytes, and
neutrophils found in the blood [reviewed in(54)]. S. pneumoniae express PC in their
bacterial cell wall and therefore are recognized by the host’s receptor. Once in the
bloodstream, S. pneumoniae will filter to the spleen and bind to SIGN-R1+ MZM. Mice
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that are SIGN-R1-deficient are more susceptible to pneumococcal infection (20, 21).
Once S. pneumoniae has bound SIGN-R1+ MZM, antigen is then believed to be presented
to the MZ B cells, which produce anti-PC IgM antibodies (21). Recently, studies done on
the human DC-SIGN have shown that this receptor also binds to S. pneumoniae. DCSIGN, a receptor expressed on DC that reside in mucosal tissue, was shown to
specifically bind to S. pneumoniae serotypes 3 and 14 in vitro (16). Yet, DC were not
observed to have any immunomodulatory effects. Therefore, further investigation needs
to target human DC-SIGN and determine the mechanism involved in initiating an
immune response after binding S. pneumoniae. Examining the murine homologue SIGNR1 can lead to a better understanding of the immunomodulatory role of human DCSIGN.
Phagocytosis
After binding antigen such as S. pneumonia MZM, will begin the process of
phagocytosis. Phagocytosis is a form of endocytosis (the process by which cells engulf
particles, molecules, and/or fluids) [reviewed in(55)]. Phagocytosis occurs when
particles are greater than 0.5 µm in diameter. Phagocytosis of microbes is a complex
process that involves multiple receptors, signaling molecules, and signaling pathways to
effectively internalize the microbe. The receptors and endosomal compartments involved
in the engulfment and clearance of microbes are discussed below.
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Receptor-mediated phagocytosis
Multiple receptors have been shown to bind microbes simultaneously [reviewed
in (47)]. Briefly, immunoglobulin Fc receptors, complement receptors, integrins, lectins,
and scavenger receptors are believed to directly bind the microbe or bind opsonins on the
surface of the microbe. Receptor binding induces many signaling pathways that use
numerous molecules to undergo proper signaling that lead to a plethora of responses like
microbial killing and the production of inflammatory cytokines and chemokines. Fc
receptors bind immunoglobulin-opsonized pathogens and complement receptors bind
complement-opsonized pathogens. Integrins are both adhesion and phagocytic receptors
and have been seen to mediate both (55). For example, the fibronectin receptor (αMβ1
integrin) has been shown to bind ligand at the substrate-adherent surface of monocytes.
This binding of ligand to receptor promotes the activation of the complement receptor
CR3 (αMβ2 integrin), which mediates phagocytosis. Lectins, such as SIGN-R1,
recognize self and non-self carbohydrates often seen on the cell wall of microbes (7, 47).
Studies with the lectin for receptor mannose have shown that ligation of receptor leads to
particle internalization (47). Scavenger receptors are well-known for their ability to bind
and internalize modified lipoproteins. The MARCO receptor is a member of the
scavenger receptors. Scavenger receptors are divided into two groups: SR-A and
MARCO. They bind diverse ligands such as polyribonucleotides, lipopolysaccharides,
and silica particles (44). It has been suggested that while scavenger receptors bind
microbes, they do not contribute to the internalization; co-receptors are required for
internalization (47).
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Phagocytic compartments
Once a receptor has bound and internalized a microbe, the formation of a
phagolysosome is initiated. The phagolysosome will fuse with compartments of the
endocytic pathway and will be degraded [reviewed in (56)]. The main compartments of
the endocytic pathway are the early endosome, late endosome, and the lysosome (56-58).
Each compartment of the endocytic pathway has been characterized based on the
intracompartmental pH, luminal composition and morphology.
The early endosome is often referred to as the major sorting station. Here,
organelle materials may get recycled to the plasma membrane, proceed to late endosome,
or be targeted to secretory vesicles (58). Using ratiometric measurements, the pH of the
early endosome has been reported to be ~ 6 [reviewed in (58)]. The structure of the early
endosome is described as multivesicular, consisting of cisternal regions with thin tubules
(57). The late endosome and lysosome are regarded by some authors as one
compartment; however there are differences between late endosomes and lysosomes.
Both contain acid hydrolases, lysosome-associated membrane proteins (LAMPS), and
lysobisphosphatidic acid (a phospholipid that plays a role in glycolipid degradation and
the transport of lipids and membrane proteins) [reviewed in (56)]. Differences between
late endosomes and lysosomes include their function and morphology. The late
endosome functions as the main site for proteolysis and the lysosome functions as the
main site for hydrolase by acid hydrolases. At the ultrastructural level, late endosomes
are observed to have a complex morphology with a multivesicular appearance containing
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cisternal, tubular and vesicular regions similar to the early endosome (59, 60), whereas,
lysosomes are observed to be spherical in shape and said to resemble vesicles (60). The
pH of the late endosome has been reported to be approximately 5.5 and the pH of the
lysosome close to 4 (56). The pH varies from cell to cell and is controlled by a complex
system controlled by the luminal environment of each compartment. A system of
vacuolar ATPases (V-ATPases) and redox chains pump protons into the luminal
compartments, which are regulated by Na+/H+ exchangers (early endosome) and Cl- ion
channels (late endosome and lysosome) (56).
The marginal zone B cell
The B cell population is comprised of several functional and phenotypically
distinct subpopulations, including newly-formed immature (transitional and preMZ B
cells), mature FO, B1 B cells, regulatory B cells, and MZ B cells (Table II). These
subpopulations have been suggested to be a result of evolutionary pressures that allowed
the host to defend against invading pathogens with and without help from T-cells (61,
62).
Recent attention has been given to MZ B cells because of their ability to provide a
rapid defense against TI bacterial antigens – an attribute lacking in TD FO B cells, which
can take up to 7 days to produce antibodies. MZ B cells in normal adults make up ~5%
of the total B cell pool in the spleen, and FO B cells comprise ~90%. Upon stimulation
by TI antigens, MZ B cells differentiate rapidly into short-lived plasma cells and secrete
IgM antibodies (10). In addition, MZ B cells have been shown to mediate TD responses
in vitro [reviewed in Allman et al (11)]. In humans, MZ B cells are found in the MZ of
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the spleen, and B cells with the MZ B phenotype are also seen in lymph nodes in the
outer extra-follicular rim (11). Yet in rodents, MZ B cells have only been demonstrated to
reside in the MZ of the spleen.
Once thought to be sessile, recent work has shown that MZ B cells shuttle
between the MZ and follicles of the spleen, resulting from the balance of two main
factors. The first is downregulation of the sphingosine 1-phosphate receptor (S1P1) that is
present on MZ B cells (15, 63, 64). S1P1, like MARCO, is also required for MZ B cells to
remain lodged in the MZ, because in the absence of S1P 1, MZ B cells are found displaced
to the white pulp follicle (64, 65). The chemokine CXCL13 and its receptor CXCR5 that
is present on MZ B cells are the second major factor important for MZ B cell shuttling.
The white pulp follicle has high levels of CXCL13 and it is believed that MZ B cells
naturally move toward this chemokine gradient (64, 65). This shuttling occurs during
homeostatic conditions (64) and in response to antigen (15, 63, 64). Antigen that has
entered by way of the MZ sinus is believed to be phagocytized by MZM and the
pathogen degradation products are then taken up by MZ B cells (15, 17). On the other
hand, some believe MZ B cells are able to bind the antigen directly and transport it to the
white pulp follicles (63). Upon exposure to TI antigens, MZ B cells will bind the antigen
via the BCR thereby initiating the BCR-mediated signaling pathway. BCR aggregation
results from antigen binding leading to phosphorylation of tyrosine residues on
immunoreceptor tyrosine activation motifs (ITAMS) located on the cytoplasmic tails of
the BCR co-receptors. Once phosphorylated, the tyrosine kinase Syk will facilitate the
initiation of downstream signaling pathways that lead to the activation of phospholipase
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C- (PLC-). In parallel to BCR aggregation, the complement receptor CD21/35 binds
complement-coated antigens and enhances BCR signaling. Activation of CD21/35 leads
to Bruton’s tyrosine kinase (Btk) signaling that causes further activation of PLC- and
also causes activation of NFB, which are both components necessary for proliferation
and clonal expansion of B cells [reviewed in (32)].
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Table 2. Splenic B-lineage subpopulations and phenotypes
B cell subset

Phenotype
+a

Location
c

Function

Frequency

Transitional T1

B220 CD23-bCD21/35low IgMhighd IgDlowe

MZ

Immature B cell

3-5%

Transitional T2/T3

B220 + CD23 + CD21/35low IgMhigh IgDhigh

MZ/Follicle?

Immature B cell

< 3%

preMZ B cells

B220+ CD23+CD21/35high IgMint/high IgDhigh

Follicle

Immature B cell

<3%

Follicular B cells

B220 + CD23 + CD21/35int IgMint/high IgDhigh

Follicle

Mature B cell
>90%
important in TD response

Marginal Zone B cells

B220+ CD23 - CD21/35high IgMhigh IgDlow

MZ

Mature B cell
important in TI response

3-5%

B1 B cells

B220 + IgMhigh IgDlow CD9f

MZ?

Mature B cell
important in TI- response

<3%

Regulatory B cells

CD1d hiCD5+

a B220/CD45 is belongs in the protein tyrosine phosphate family a nd is a

?

Produce IL-10
major cell surface glycoprotein. It

primarily recognizes the proB cell stage through mature B cells.
b

CD23 is a type II transmembrane glycoprotein present on resting follicular B cells. CD23 is also a low
affinity receptor for IgE.
c

CD21/35 are expressed by mature B cells and CD21 is a receptor for complement component C3d and
Epstein-Barr virus.
d

IgM a class of immunoglobulin expressed on the surface of immature and mature B cells.

e

IgD a class of immunoglobulin expressed on the surface of mature B cells.

f

CD9 is a cell surface glycoprotein important for cell adhesion and migration.

1-2%
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Marginal zone B cell production in young and old mice
In normal young adults, B cell development starts in the bone marrow. B cells
arise from common lymphoid progenitors (CLP) and through a series of gene
rearrangements (V(D)J regions) develop into a pro-B cell, pre-B cell, and an immature B
cell phenotype (Fig. 3). An immature B cell will leave the bone marrow and enter the
spleen. In the spleen, immature B cells will transition into T1, T2/T3 transitional B cells,
and pre-MZ B cell before taking on the mature MZ B or FO B cell phenotype.
Production of MZ B cells is influenced by several factors including but not limited to:
interleukin-7 (IL-7) cytokine and receptor levels, B cell receptor (BCR) signal strength,
the helix-loop-helix protein E2A, and more recently the adapter molecule SHEP1 (SH2
domain-containing Eph receptor-binding protein 1) [reviewed in (11, 32, 66-68)]. For
proper MZ B cell development, Notch 2 levels need to be high, and E2A protein activity
and BCR signal strength need to be low. An interesting observation is that in age
decreases in IL-7 (69, 70), BCR signal strength (71-74), and E2A protein levels (75-77)
have been observed (Fig. 4). Since these conditions favor MZ B cell development over
FO B cell development, a shift towards MZ B cell differentiation at the expense of FO B
cell production may be predicted. However, increases in MZ B cell numbers in age have
only been reported by the Cambier group using a BCR transgenic mouse model (78).
Furthermore, results in this dissertation and the work by Frasca et al. (79) show a
decrease in MZ B cells with age.
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Figure 3. MZ B and FO B cell production in young mice. Figure depicts normal B
cell development which arises in the bone marrow. B cells arise from common lymphoid
progenitors (CLP) and through gene rearrangement (V(D)J regions) will progress through
a pro-B cell, pre-B cell, and an immature B cell phenotype. An immature B cell will
leave the bone marrow and enter the spleen. In the spleen, immature B cells will
transition into Transitional B cells before taking on the mature MZ B or FO B cell
phenotype. It has been suggested that MZ B and FO B cells also possess the ability to
interchange, taking on the other’s phenotype depending on the environmental conditions.
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bone marrow)
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Figure 4. Factors important for the production of MZ B and FO B cells in young
and old mice. Immature B cells will develop into FO B cells as a result of the
availability of high amounts of the transcription factor E2A and increased BCR signal
strength induced by IL-7 secreted by bone marrow stromal cells. MZ B cells will arise
when there is less E2A available and the BCR signal strength is low. Red text
corresponds to the factors that are present in the aged microenvironment.
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MAdCAM1+ marginal zone sinus and metallophilic macrophages
The MZ compartment is also comprised of non-immune cells including the
MAdCAM1+ sinus-lining endothelial cells, which line the site where pathogens and
recirculating lymphocytes enter into the MZ (30). MAdCAM1 is a homing receptor on
the high endothelial venules (HEV) of gut-associated lymphoid tissue (80, 81).
MAdCAM1 expressed on HEV has been shown to be responsible for lymphocyte traffic
into these mucosal sites. However, similar roles for the MAdCAM1 expressed on the
endothelial cells that form the MZ sinus could not be demonstrated (82). Recent studies
have implicated the role of MAdCAM1 in the homing of bone marrow- derived
hematopoietic stem cells into the spleen (83). The MZ sinus is a capillary extension of
the central artery. Ultrastructurally, the MZ sinus of rats was found to have a basement
membrane with discontinuous walls wider on the MZ side than the follicle side (36).
Lymphocytes, macrophages, plasma cells, and occasionally polymorphonuclear
leucocytes were found adjacent to these discontinuities; presumably these discontinuities
are wide enough for the passage of cells as large as macrophages.
The positioning of the MAdCAM1+ sinus-lining cells is thought to be under the
influence of sphingosine-1-phosphate receptor 3 (S1P3). S1P3 is a G-protein-coupled
receptor belonging to a family of five different isotypes, S1P1-5, found ubiquitously on
most cells including lymphocytes [reviewed in (7)]. The known ligand for the S1P1-5
receptors is sphingosine-1-phosphate (S1P), which is a lysophospholipid found
predominantly in peripheral blood and produced by many cells including macrophages
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(7). In a study by Girkontaite et al., S1P3- deficient mice showed morphological
disruptions in the MAdCAM1+ sinus-lining cells that resembled multiple layers of
MAdCAM1+ cells (84). Disruptions in the MZ sinus most likely would lead to a
hindrance in passage of cells and antigens through the discontinuities of the sinus. Studies
presented in this dissertation will examine the MAdCAM1+ MZ sinus in old mice to
determine if there are any gross morphology alterations, such as disruptions in cell
positioning.
Situated along the inner border of the MZ sinus facing the white pulp area, MMM
form a tight ring around the MZ sinus. As seen with the MAdCAM1+ sinus, S1P3 has
also been found to be necessary for the positioning of MMM (84). MMM express the
cell surface adhesion molecule Siglec-1 (sialoahesin) that can bind sialic acid containing
molecules on the surface of pathogens and immune cells [reviewed in (7, 30)]. Siglec-1,
however, is not involved in the internalization of antigen and requires other receptors for
phagocytosis (7). MMM produce the cytokines interferon-α and interferon-β after
challenge with virus (30). MMM have a high content of nonspecific esterase (85). This
enzyme is involved in the cleavage of fatty acids and removal of apoptotic cells. In sum
an alteration in MMM may impinge on the ability to remove dead cells that accumulate
due to natural cellular turnover. Furthermore, MMM positioning is continuous with the
MZ sinus. Therefore, it is also conceivable that disruptions in the sinus can indirectly
cause damage to this pool of macrophages.
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Survey of relevant age-associated declines in immune function
The elderly population 65 years and older has a greater susceptibility to infections
than young adults. Histological examination of splenic tissues with age have found
reduced germinal centers (29) and disrupted T cell zone (PALS) of the spleen with visual
changes in the MZ (26). It has been well documented that aging is associated with a
decline in cell-mediated and humoral immunity. The thymus involutes and the naïve T
cell pools decline with age while the memory T cell pool increases (86, 87). In terms of
the humoral immune response, the mature B cell pool (FO B cell phenotype) in the spleen
has been reported to be similar in young and old mice (88); however, the pre B cell pool
in the bone marrow has been reported to decrease when compared to young mice (88).
The maintenance of the mature B cell pool in the spleen is thought to be due to an
accumulation of long-lived mature B cells in the old and not a result of turnover with
newly formed B cells (27). Recent studies determined if B cells in old mice developed at
similar rates when compared to B cells of young mice (89, 90). BrdU labeling showed
that the production rate of immature B cells is similar in young and old mice, yet newly
made immature B cells of old mice were less frequent in the spleens of old mice when
compared to young mice (89). More recently, the migration of immature B cells to the
spleens of old mice was examined by transferring immature B cells from young mice into
old and young mice (27). Results found that the number of donor immature B cells in old
mice was significantly reduced when compared to the amount of donor cells recovered in
young mice. Together these data suggest that the reduced frequency of newly made
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mature B cells observed in old mice is the result of alterations in the splenic
microenvironment hindering newly formed B cells from populating the spleen.
B cells are ultimately important for the production of antibodies against invading
pathogens. In age, levels of serum antibody against tetanus toxoid, plant mitogens and
allogenic lymphocytes of older humans are reduced compared to young adults and are
maintained for shorter periods (91-93). Moreover, the antibodies produced by aged
individuals have been reported to have reduced affinity and avidity when compared to
antibodies of young adults (94-96).

Reports using mice have shown antibodies

generated in old mice against PC, found in the cell wall of S. pneumoniae, are less
protective when compared to the antibodies generated in young mice (73, 74). PCspecific hybridomas were generated from young and old mice and isolated RNA was
used to determine which immunoglobulin VH and VL gene families (important for the
variable region of the immunoglobulin) were utilized. Results revealed that 12/13 of the
hybridomas tested from young mice expressed restricted VH and VL gene families,
whereas only 2/13 of the hybridomas from old mice expressed the same VH genes and
none expressed the VL gene family seen in young. Thus, the repertoire of
immunoglobulin gene usage appears to change with age. Furthermore, the antibodies
generated against PC in old mice were able to cross react with a number of unrelated
antigens (74). In humans, the IgM antibody titers of elderly individuals vaccinated
against S. pneumoniae or pneumococcal polysaccharides has also been reported to be
reduced when compared to young adults (97). Given that S. pneumoniae infection can
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elicit a TI immune response these data suggest a breakdown in the TI immune response
in the old. As mentioned previously, MZM are key in the response to TI antigens.
Although there are no reports on the immune response of MZM in age, whole
splenic macrophages (13), peritoneal macrophages (98, 99), and alveolar macrophages
(100) of aged rodents have been reported to decrease in function when compared to
young rodents. Studies by Chelvarajan et al. measured the cytokine profiles of whole
splenic macrophages in vitro after treatment with the TI antigens trinitrophenol (TNP)LPS and TNP-Ficoll. Results showed that aged macrophages secreted reduced amounts
of the proinflamatory cytokines IL-6, TNF-α, IL-1β, and IL-12 and elevated amounts of
the anti-inflammatory cytokine IL-10 when compared to young mice (13). Similarly,
studies with peritoneal macrophages isolated from young and old mice found that after
LPS stimulation, cultured macrophages from old mice produced less IL-6 and TNF-α
when compared to young mice (98). It was further determined by Boehmer et al. that this
decrease was due to decreases in p38 and c-jun NH2-terminal(JNK) mitogen-activated
protein kinase (MAPK), which are transcription factors important for the production of
IL-6 and TNF-α. Notably, this same study found no differences in the surface
expression of TLR4 (recently shown to interact with SIGN-R1) between age groups.
There is also a wide body of literature that has found heightened levels of
proinflammatory cytokines with increasing age (101, 102). This heightened
proinflammatory state is termed “Inflam-aging” and is described as the underlying factor
attributing to the immunosenescence observed in aging. It has been suggested that
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phagocytic cells such as macrophages and neutrophils are responsible for increased
production of proinflammatory cytokines in age. It is argued that this hyperproinflammatory state result in damage to neighboring immune cells and thereby
contributes to immunosuppressive effects. Whether a hyper-proinflammatory state can
lead to a hindrance in normal cell frequencies still, however, remains to be elucidated.

Goals of my experiments
The MZ of young mice is a highly organized region comprised of MZM, MZ B
cells, the MZ sinus and MMM. Since little is known about changes in the cellular
components of the MZ with age, the goal of this dissertation is to compare the MZ
compartment in old and young mice and to assess the age-associated alterations of
the MZ. Results presented in this dissertation first show that there is a morphological
disruption of the MZ with age and decreases in MZM and MZ B cell frequencies are seen
in old mice. Results have also determined the possible micro-environmental factors
contributing to this loss of MZM and MZ B cells with age. Lastly, the functional
differences of MZM of young and old mice were investigated. These results determined
that the decline in the TI immune response reported in age is a result of loss in cell
frequency/number and not a cell intrinsic defect.

CHAPTER III
MATERIALS AND METHODS
Animals
Female BALB/c mice were purchased from Harlan Laboratories (Indianapolis, IN) or
Charles River (Wilmington, MA) through contract with the National Institute of Aging at
17-18 mo of age and from Harlan Laboratories at 6-8 wks of age. Upon receipt, the
animals were housed at the Animal Research Facility (Loyola University Medical Center,
Maywood, IL) under specific pathogen-free conditions until sacrificed. Old animals with
any visual abnormalities such as enlarged spleens and presence of tumors were not used
in these studies.
Tissue histology
Spleens were fixed in 10% buffered formalin and processed using an automatic tissue
processor, dehydrated through graded alcohols, cleared in xylene and infiltrated with
paraffin. Paraffin sections were cryosectioned on a microtome (4 µm) and applied on
Superfrost®/ Plus microscope slides (Fisher Scientific, Pittsburg, PA). Sections were then
treated with xylene to deparaffinize the tissue and rehydrated in successive decreasing
grades of alcohol. The splenic sections were stained with hematoxylin and eosin (H&E).

32

33
Sections were cleared and mounted. Slides were viewed and photographed with a Leitz
Diaplan microscope (W. Nuhsbaum, Inc., McHenry, IL).
Tissue specific scoring of MZ architecture
H&E stained slides were blinded and four well-oriented white pulp areas were chosen for
each animal and scored independently by two investigators. In consultation with a
pathologist, criteria were established to evaluate the morphology of the MZ. The
interface between the white pulp and MZ was evaluated subjectively for the percent of
distortion around each white pulp area and given a score ranging from 0-4. A score of 0
corresponded to  75% distortion, 1 was  50% but  75%, 2 corresponded to  12.5%
and  50% distortion, 3 corresponded to  12.5% distortion, and finally a score of 4
corresponded to no evidence of interface distortion. For each white pulp area, the extent
of interface distortion was also evaluated by determining the percent of radius
involvement. This was defined by taking the area that was distorted and evaluating the
amount of distortion that protruded toward the center of the white pulp. As before, for
each white pulp area, a score ranging from 0-4 was given. A score of 0 was  20%, 1
corresponded to  15%, 2 corresponded to  10%, 3 corresponded to  5%, and finally 4
corresponded to no distortion protruding inwards. The summation of the interface
distortion and percent of radius involvement per white pulp area was determined and
given a total score ranging from 0-8. The final distortion was characterized either as
severe (0-2), moderate (3-4), mild (5-6), or minimal (7-8). Finally, the average score of
all four white pulp areas per animal was determined and reported for each mouse.
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Tissue specific scoring of MAdCAM-1+ MZ sinus lining cells
MZ sinus lining cells were revealed by immunofluorescence staining of spleen frozen
sections from the middle 1/3 of the spleen. A tiled image (25x) of a complete cross
section of spleen (6-8µm) from each animal was compiled using a Zeiss LSM 510
confocal microscope (Carl Zeiss, Inc., Jena, Germany). Using LSM image browser
software (Carl Zeiss, Inc), the lines of MAdCAM-1+ cells were outlined using the
polyline drawing and measurement tools. Measurements of the length of MAdCAM-1+
cells enveloping all white pulp areas in a single section were recorded. Disrupted lengths
were then discriminated and measured by identifying dispersed, non-compact MAdCAM1+ staining. Relative proportion of the disrupted areas verses total length of the lines
covered by MAdCAM-1+ cells was calculated.
Immunocytochemistry
One-third of each spleen was frozen in Tissue-Tek® O.C.T. freezing medium (Sakura,
Torrance, CA) and stored at -70oC. Frozen spleens were cryosectioned (6-8 µm) onto
Superfrost®/ Plus microscope slides. Splenic sections were fixed in acetone for 10 min,
blocked in 5% normal mouse serum (NMS) (The Jackson Laboratory, Bar Harbor,
Maine) and then incubated for 1 hr with an unconjugated rat anti-mouse IgG2a antiMAdCAM-1 mAbs (MECA-367; BD Pharmingen, San Diego, CA) followed by a 30 min
incubation with alkaline phosphatase conjugated mouse anti-rat IgG2a (2A 8F4; Southern
Biotech, Birmingham, AL) to detect the MZ sinus lining cells. Positive cells were

35

revealed using Alkaline Phosphatase Substrate Kit III (Vector Laboratories, Burlingame,
CA). For double immunocytochemistry, sections were then blocked with 5% NMS for 20
min and subsequently incubated for 30 min with either unconjugated rat anti-mouse IgG1
anti-MARCO mAbs (ED31; BMA Biomedicals, Switzerland) or unconjugated armenian
hamster anti-mouse SIGN-R1 (ebio22D1; eBioscience, San Diego, Ca) followed by a 20
min incubation with horseradish peroxidase (HRP) conjugated mouse anti-rat IgG1 (G1
1C5; Southern Biotech) or rabbit anti-armenian hamster IgG HRP (Abcam Inc.,
Cambridge, MA), respectively, to detect MZM. Positive cells were revealed using DAB
Substrate Kit for Peroxidase (Vector Laboratories). All antibody incubations were at
room temperature. Slides were counterstained with Nuclear Fast Red (Vector
Laboratories) for 30-60 seconds, mounted with VectaMount (Vector Laboratories) and
viewed and photographed with a Leitz Diaplan microscope.
Tissue specific scoring of MZM
MARCO was revealed by immunocytochemical staining of spleen frozen sections. Slides
were blinded and four well oriented white pulp areas were chosen per animal and scored
independently by two investigators. Each area was given a score of 1, 2, or 3 for the
abundance of MARCO+ MZM and the percent of the continuity of MZM encircling each
white pulp area. A score of 3 equated to a high abundance of MZM present that tightly
encircled the MZ sinus. A score of 2 equated to a moderate abundance of MARCO +
MZM that partially encircled the MZ sinus. Finally, a score of 1 equated to low or virtual
absence of MARCO+ MZM that, if present, were found in patches along the MZ sinus.
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An average score of the four white pulp areas graded was determined and reported for
each individual animal.
Immunofluorescence and confocal microscopy
Cryosections of spleen were fixed in acetone for 5 min and incubated with Super Block
(ScyTek Laboratories, Inc., Cache, UT) for 5 min according to manufacturer’s protocol.
Sections were incubated at room temperature with primary antibodies for 1 hr followed
by respective secondary antibodies for approximately 30-45 min. To identify MZ sinus
lining cells, sections were stained with unconjugated rat anti-mouse MAdCAM-1
followed by goat anti-rat Alexa Fluor® 633 (Invitrogen, Carlsbad, Ca). For isotype
control, rat IgG2a unlabeled with goat anti-rat Alexa Fluor® 633. To reveal MMM,
sections were incubated with fluorescein isothiocyanate (FITC) conjugated rat antimouse CD169 (MOMA-1; AbD Serotec, UK). For isotype control, rat IgG2a FITC. To
reveal MZM, sections were stained with unconjugated armenian hamster anti-mouse
SIGN-R1, goat anti-armenian hamster IgG biotin (The Jackson Laboratory) and
Streptavidin (SA)-Dylight™ 549 (The Jackson Laboratory). For isotype control,
Armenian hamster IgG. Sections were blocked with 5% normal armenian hamster serum
for 20 min and stained for co-localization of MARCO using unconjugated rat anti-mouse
MARCO followed by donkey anti-rat Dylight™ 488 (The Jackson Laboratory). Isotype
control used, rat IgG1. To reveal CCL21, sections were stained with goat anti-mouse
CCL21 (R&D Systems) and donkey anti-goat Alexa 555 (Invitrogen). For isotype
control, goat IgG (Jackson Laboratory). Sections were blocked with 5% normal rat
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serum for 20 and stained for MZ sinus lining cells as a landmark using unconjugated rat
anti-mouse MAdCAM1 followed by donkey anti-rat Alexa 488 (Invitrogen). For isotype
control, rat IgG2a (AbD Serotec). Slides were mounted with fluorescent mounting
medium (Dako, Carpinteria, CA) and viewed using a Zeiss LSM 510 confocal
microscope (Carl Zeiss, Inc., Jena, Germany).
In vivo uptake of dextran by MZM
Using a protocol previously described by Ato et al. (43), mice were injected i.v. in the tail
vein with 200 µl of dextran-FITC (500,000 MW, Invitrogen) at 100µg/ml in sterile PBS.
After 45 min, the mice were sacrificed and spleens harvested. One third of the spleen
was placed in Tissue-Tek® O.C.T. freezing medium for immunofluorescence analysis
and the remaining 2/3 was used for flow cytometry analysis (as described below). For
co-localization of MARCO with dextran-FITC positive cells, cryosections were
incubated with unconjugated rat anti-mouse MARCO followed by donkey anti-rat
Dylight™ 488 (as described above). Slides were mounted with fluorescent mounting
medium and viewed using a Zeiss LSM 510 confocal microscope.
Flow cytometry – revisited
Flow cytometry is a highly sophisticated instrument that can be used to gather a
plethora of information about a cell population such as the cell size, cells
frequency/number, and amount of protein expressed on the cells surface (103). A cell
can be identified via flow cytometry analysis through the use of fluorescently labeled
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antibodies that recognize the cells antigens. Current flow cytometry methods utilize the
use of a multiple fluorescently labeled antibodies for the precise identification of cell
populations. After cells are stained with the appropriate antibodies they are run through
the flow cytometer. Cell samples are suspended in saline solution, and 1000 cells/second
are passed through the flow cytometer like a stream. At the integration point of the
instrument each cell is hit with a laser beam and information about how the cell scatters
light and the fluorescence of the conjugated antibodies bound to the cell is recorded.
Light scattered in the forward direction is called the cells forward scatter (FSC).
The FSC gives information about the size of the cell – small cells have low FSC and
large cells have high FSC. Light scattered in angular directions is called the side scatter
(SSC). The SSC gives information about the cells granularity. Cells such as neutrophils
have high SSC because they are highly granular due to high levels of lytic enzymes
within the cell compared to lymphocytes that have virtually no lytic enzymes.
The fluorophores conjugated to the antibodies each have a unique excitation and
emission spectrum. The simultaneous measurement of multiple fluorescently labeled
antibodies on a cell will result in spectral overlap in the emission spectrums. Special
filters will correct for this overlap, however, compensation also needs to be utilized.
Compensation is the process by which the spectral overlap of the interfering fluorophore
is subtracted as a percentage of the signal. For this subtraction to be achieved single
fluorescently stained beads/cells for each fluorophore used to mark the cell need to be run
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on the cytometer before the cell sample is run. Once compensations are set the
experimental samples are ready to be run through the flow cytometer.
Lasers are used to excite the fluorophores and optical filters are used to separate
emission of varying wavelengths. Optical filters can be either high pass (for one
fluorophore detection; allows light of high wavelengths to pass while attenuating low
wavelengths), short pass (allows light of short wavelengths to pass while attenuating light
of high wavelength), or band pass (for multiple fluorophore detection; a combination of
low and high pass filters). A blue 488 nm, red 633 nm (HeNe), and a violet 405 nm laser
are in the FACSCanto™II cytometry used at the Loyola University Medical Center Core
Facility.
Analyzing data gathered
For years the isotype antibody of the antibody used to target antigen was used as
the control to determine where the positive cell populations of interest separated from the
negative cell populations. In the last decade the use of fluorescence minus one (FMO) has
become the standard for flow cytometry controls (104). FMO employs all the
fluorophores used to target a population except the one of interest to determine the
positives and negatives of that particular population. Once the gates are determined
populations of cells can be revealed through recognition of protein determinants known
to be associated with the cell. Analysis of the data collected by the flow cytometer is
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done using Tree Star FlowJo software version 7.5.5 (Becton Dickinson, Mountain view,
CA).
Flow cytometric staining for identification of MZ B cells, FO B cells, MZM, CCR7 +
MZM, dextran+ MZM, pHrodo+ MZM, and CD4+ T cells
Splenocytes, from approximately 1/2 - 2/3 of each spleen, were obtained by
gently pressing the splenic tissue between two frosted glass slides. The dispersed cells
were collected in RPMI 1640 supplemented with 10% FBS, 1% L-glutamine, 1%
penicillin/streptomycin, and 500 µl M β2-ME (referred to as media here on end), and
small clumps were allowed to settle in a conical tube and discarded. Erythrocytes were
lysed with 0.8% ammonium chloride solution and incubated on ice for 4 min. For fourcolor analysis of MZ B and FO B cells, 1 x 106 cells per sample were incubated with rat
anti-mouse CD23-PE-CY7 (B3B4; eBioscience), rat anti-mouse B220-FITC (RA3-6B2;
Southern Biotech), rat anti-mouse CD21/35-PE, and rat anti-mouse IgM-PE-Cy5.5 (II/41;
eBioscience) for 20 min on ice, protocol modified from Won et al. (105). Cells were then
fixed in 1% paraformaldehyde and the samples were analyzed using FACS Canto II with
Tree Star FlowJo software version 7.5.5. MZ B cells were identified as CD23 - B220+
CD21/35high IgMhigh. FO B cells were identified as CD23+ B220+ CD21/35int IgMint/high.
For MZM characterization, approximately 1/2 - 2/3 of each spleen was treated
with Collagenase D (Roche Diagnostics, Indianapolis, IN) or without (as described
above) for 1.5 hr at 37oC, and the single cell suspension was recovered after gentle
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filtration of the minced tissue through a fine nylon mesh. The erythrocytes were lysed by
0.8% ammonium chloride and the cells were washed and resuspended media. For twocolor analysis to identify MZM, 1 x 106 cells per sample were pretreated on ice with rat
anti-mouse CD16/32 FcR-block (FCR4G8; AbD Serotec) and subsequently incubated
with either allophycocyanin (APC)-Cy7 labeled rat anti-mouse CD11b (M1/70;
eBioscience) or biotinylated CD11b (M1/70; eBioscience) with armenian hamster antimouse SIGN-R1-Alexa Fluor® 647 (22D1; eBioscience) for 20 min on ice. Streptavidinperidinin chlorophyll protein (SA-PerCP; 16904; BD Pharmingen) was used as a secondstep reagent. For isotype control to SIGN-R1, armenian hamster anti-mouse IgG-Alexa
Fluor® 647 (22D1; eBioscience) was incubated for 20 min on ice. Cells were fixed in 1%
paraformaldehyde, except in experiments using dextran; cells were resuspended in PBS
and analyzed using flow cytometry.
For characterization of CCR7+ MZM, 1 x 106 cells per sample of dispersed splenocytes
were incubated with anti-mouse CCR7-PE (eBioscience) for 30 min in 37o C followed by
pretreated on ice with rat anti-mouse CD16/32 FcR-block and subsequently incubated
with antibodies to identify MZM (described above). For isotype control to CCR7, Rat
IgG2a (eBioscience) for 30 min in 37o C. For characterization of CD4+ T cells, thymus
was removed and single cell suspensions were made and resuspended in media. For one
color identification of CD4+ T cells, 1 x 106 cells per sample were stained with antimouse CD4-PE (eBioscience). Cells were fixed in 1% paraformaldehyde and
resuspended in PBS and analyzed using flow cytometry.
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For characterization of pHrodo + MZM splenocytes obtained from both young and
old cells were harvested and allowed to adhere onto 35 mm culture plates for 1 hr in
media. Non-adherent cells were removed and 125 µl of 125µg/ml pHrodo were added
and allowed to incubate in 37 C for 2 hrs. Cells were collected using a policeman
scraper, stained for to identify MZM, and analyzed using FACScanto, which records
fluorescence of the phagocytized pHrodo in the PE channel.
Adoptive transfer of mature B cells to young and old recipient mice
Spleen was prepared from young (IgMb) C.B17 mice and transferred into young
and old (IgMa) BALB/c mice. C.B17 mice differ from BALB/c mice in expression of the
IgM allotype, allowing for donor cells to be identified from recipient cells. Donor spleen
cells were dispersed as described above, and then donor mature B cells were purified
using a magnetic antibody cell sorting (MACS) B cell isolation kit (Miltenyi Biotech)
according to the manufacturer’s protocol.

Each recipient mouse received an intravenous

injection of 20 x 106 donor purified mature B cells in 200 µl PBS. Spleens from recipient
mice were harvested 6 hr post-transfer. Donor MZ B and FO B cells were analyzed by
flow cytometry stained with antibodies previously mentioned for the identification of MZ
B and FO B cells (note: anti-allotype IgM biotin was used in place of rat anti-mouse IgM
PE-Cy5.5 for identification of donor cells).
For detection of MZ B cells in bone marrow, lymph node and blood cell
preparation was performed as follows: Bone marrow was harvested by flushing the tibias
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and femurs from one leg of each mouse using a 27-gauge needle and a 10 ml syringe
filled with media. Aggregated cells were separated by pipetting up and down with a 5 ml
pipette. Cells were centrifuged and the cell pellets were resuspended in 5 ml media.
Inguinal, axial, and cervical lymph nodes were removed from each mouse and single cell
suspensions were made by rubbing the nodes between two frosted glass slides. Cells
were pelleted and resuspended in 3ml media. Blood was collected by cardiac puncture
after mice were CO2 asphyxiated. To prevent blood coagulation blood is drawn from the
cardiac chamber using a 10 ml syringe containing 1 ml citrate to yield a total volume of
1.5-2 ml blood + citrate. Blood suspensions were diluted with 2 ml of PBS and 3 ml
lymphocyte separation medium was added. The preparation was centrifuged for 30 min
at room temperature at a speed of 1500 rpm. Lymphocytes were recovered by gentle
pipetting. Media was then added to the cell suspension and centrifuged for 7 min at 4°C.
Cells were pelleted and resuspended in 1 ml media.
Quantitative RT-PCR analysis of expression of the chemokine CCL21
Quantitative RT-PCR analysis was performed on spleen from young and old
mice. Spleens were frozen in liquid nitrogen for homogenization at a later date.
Homogenization was done using a rotor-stator homogenizer. Total RNA was isolated
from whole homogenized spleen using the Qiagen RNeasy Kit (Valencia, CA) according
to the manufacturer’s suggested protocol. Complementary DNA (cDNA) was
synthesized using the Amersham First Strand cDNA synthesis kit (Buckinghamshire,
UK) and real-time PCR analysis was performed using a GeneAmp 2400 thermal cycler
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(PerkinElmer, Wellesley, MA). Primers were as follows: CCL21: forward 5’ –
AAAGAAAGGAAAGGGCTCCAA-3’ and reverse
5’TGCGCTCATCTTAGGCTTTGT-3’. The real-time PCR thermal cycler profile was
run as follows: one cycle at 50°C for 2 min, one cycle at 95°C for 10 min, 40 cycles of
denaturing at 95°C for 15 seconds, and annealing and elongation at 60°C for 1 min,
followed by a dissociation protocol run to test the melting temperature of the product.
The data were analyzed using GeneAmp 5700 SDS software (Applied Biosystems). The
relative expression levels for each sample were calculated by determining the ratio of the
number of copies/µl for CCL21 to the number of copies/µl of HPRT.
pHrodo treatment and analysis via microplate reader
Splenocytes were harvested as described above from young and old mice and
allowed to adhere onto a 96 well plate at 1 x 106 cells/well. Non-adherent cells were
washed after 1 hr and 100µl of 100µg/ml pHrodo were added per well and allowed to
incubate in 37 C for 2 hrs. After 2 hrs, the 96 well plate was placed in a microplate
reader and cells were excited using a 550 nm laser and the emission was recorded at 600
nm. The percent net effect was determined by using the manufacture suggested formula.
Ex vivo treatment of pHrodo
Young and old mice were injected with dextran-FITC (as described above). Splenocytes
were harvested and 4 x 106 splenocytes were allowed to adhere onto 1 ml chamber slides
(Nunc Labtek) for 1 hr at 37°C incubator. After 1 hr non-adherent cells were removed
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and pHrodo™ S. aureus BioParticles® (pHrodo) (Molecular Probes™ Invitrogen) were
given at 100 µg/ml in Hank’s balanced salt solution HBSS (GIBCO® Invitrogen)
containing 20 mM Hepes (GIBCO® Invitrogen) for 1.0-1.5 hr. After 1.0-1.5 hr cells were
viewed using a Leica TCS SP5 confocal microscope (Leica) remaining incubated at
37°C. Each chamber containing cells from one animal was examined for 15 min. The
following exceptions were made with time lapse experiments: pHrodo was administered
and 10 min after administration, MZM were imaged once every min (for total of 60 min)
or once every 2 min (for total of 120 min). For each animal sample dextran+ pHrodo+
MZM were located and approximately 10-15 MZM were imaged/animal live at 5000x
magnification. Three criteria were needed to qualify as an MZM: first, cells needed to be
dextran+; second, cells needed to be pHrodo+; and lastly, cells needed to have
macrophage morphology.
Phagocytosis of pHrodo by MZM was measured using ImageJ version 1.43u. For
each animal sample, single images of dextran+ pHrodo+ MZM were evaluated for the
mean fluorescence intensity (MFI) of pHrodo and dextran within MZM, and the number
of phagocytic compartments/MZM. For young mice approximately 7-10 MZM images
were analyzed and for old mice 4-5 MZM images were analyzed. The average value was
reported for each measurement assessed.
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Statistical analysis
Statistics were calculated using Graphpad Prism software (version 5.01). To compare
compared differences in cells populations between young and old mice Mann-Whitney
test or Unpaired t-test was used. To determine if there was a direct correlation between
changes in one cell type to another Pearson Correlation was applied where appropriate.

CHAPTER IV
THE ANATOMICAL AND CELLULAR CHANGES IN THE
MARGINAL ZONE OF YOUNG AND OLD MICE
This chapter provides a survey of the morphological and cellular
alterations of the MZ with age. Initial observations revealed visual disruptions of the MZ
with age. These disruptions were first observed on H&E cross sections of mice spleens,
which could not identify specific cell population involved in the alterations. By
examining the various cell components that make up the MZ in young and old mice, the
populations responsible for these morphological disruptions were determined. Given that
the cells that comprise the MZ are vital for the proper immune response to TI antigens,
establishing which cells are altered with age would provide insight into the reported age
associated declines in immunity.
Previously established methods, as well as novel methods using flow cytometry
and tissue histology, were used to identify and properly assess MZ cells and to determine
if alterations were present in old mice. Results showed gross alterations in the structure
of the MZ with age are attributed to decreases in the MZM and MZ B cells pools and
disruption in the positioning of the MAdCAM-1+ lining cells and MMM. Results also
showed that in ~20% of old mice, a “young-like” phenotype persist within the MZM and
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MZ B cell compartment. Therefore, unless animals fall into this 20th percentile
of having young-like cell frequencies, a consequence of a reduction in cells of the MZ
with age can have an impact on an efficient immune response.
Morphological disruption of the splenic MZ areas in old mice
The morphological organization of the MZ region in young animals is well
defined (7, 8, 106). In consultation with a pathologist, two morphological criteria were
selected to discriminate the degree of morphological disruption in the MZ areas of aged
spleens. Sections of H&E stained spleens from young and old mice were scored
independently by two investigators, “blinded” to the identity of the specimens. The
criteria used were (1) the interface distortion (defined as the boundary between the white
pulp area and the inner edge of the MZ) and (2) the percent radius involvement (defined
as the percentage of interface distortion protruding towards the center of the white pulp
(Fig.5). Each criterion was given a score ranging from 0-4 (severe to minimal). Four
MZ areas were scored for each spleen. A sum of scores for both criteria was calculated
for each MZ area, and this sum was averaged to yield a value for each individual spleen
(Fig.5B) (detailed in material and methods). The MZ from young mice (2-6 months,
Fig., top panels) uniformly encircled the white pulp areas. However, the MZ of old mice
(18-23 months, Fig.5A, bottom panels) showed a great deal of variability and many had a
high degree of distortion around the white pulp compared to spleens from young mice. In
many old mice, the splenic MZ areas were diffuse and some were even difficult to
discern. Figure 5B shows that on average, the morphology of splenic MZ from old mice
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could be histologically discriminated from those of young mice. Of note, the splenic MZ
from some old mice retained a “young-like” morphology, in which the MZ areas appear
to have intact organization by the criteria assessed (Fig. 6).
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Figure 5. Morphological comparison of the MZ architecture of young and old mice.
(A) Fixed, paraffin-embedded cross-sections of spleens stained with H&E demonstrating
the range of disruption in the MZ of young and old mice. The top panels are a 25x and
50x magnification of a white pulp area from one representative young mouse. At 50x
magnification the interface distortion (depicted by the inner line) is uniform and the
percent radius involvement (arrows point to minimal protrusion of cells inward) is ≤ 5%.
The lower panels are a 25x and 50x magnification of a white pulp area from one
representative old mouse. At both low and high power magnification the interface
distortion is severe and the percent radius involvement is ≥ 20% (arrows point at cells
protruding into the white pulp area). (B) Qualitative scoring of MZ histology as detailed
in Materials & Methods. The average score for four white pulp areas from each of six
young (2-6 mo), filled circles and six old (18-23 mo), open squares is shown. The
horizontal bars indicate the average and SEM for each group. p = 0.0021 determined by
Unpaired t-test .
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Figure 6. Representative images of H&E stained splenic sections from young and
“young-like” old mice. The top panel is a 50x magnification of a white pulp area from
one representative young mouse. The boundary of the MZ is visible and the interface
distortion is uniform and the percent radius involvement is ≤ 5%. The bottom two panels
are 50x magnification of white pulp areas of old mice that exhibit “young-like” MZ. The
interface distortion and percent radius involvement are similar to that of which is
observed in young mice.
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Alterations in the cells of the MZ region in spleens of old mice revealed by
immunofluorescence staining
The MZ is a compartment composed of different types of macrophages and B
cells that are highly organized for the function of detecting and clearing antigens from the
blood. Therefore, any changes in these cells or their position within the MZ of old mice
could account for the decreases in clearance of TI antigens with age. Staining was
included for MAdCAM-1+ MZ sinus lining cells to provide a landmark, since both MZM
and MMM relate in position to the MZ sinus. Similar to numerous reports of spleens
from young mice, MAdCAM-1+ MZ sinus lining cells (red or purple) showed continuous,
thin rings surrounding white pulp areas (Fig. 7A top panel). In contrast, the MAdCAM1+ cells from old mice exhibited a less even, more diffuse distribution and often appeared
as multiple layers of cells oriented toward the white pulp (Fig. 7A bottom panel). Figure
6A shows an assessment of MAdCAM-1+ disruptions in young and old mice. In spleens
from young mice, MMM (green) were closely aligned with the MAdCAM-1+ cells and
formed a continuous line of cells on the follicular side of the MZ sinus (Fig. 8A top
panel), similar to published examples (7). In the spleens from old mice, the MMM were
aligned along the MZ sinus but were highly diffused into the white pulp/follicle area (Fig.
8A bottom panel). The diffused distribution of MAdCAM-1+ cells and MMM was
consistently observed in old mice.
The most pronounced difference between old and young spleens was in the
distribution of the MZM (marked by expression of either MARCO or SIGN-R1). MZM
in young spleens formed continuous rings on the outer edge of the MZ sinus (Fig. 8B top
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panel), similar to numerous published reports (18-21, 40). However, in many old
spleens, MZM appeared to be reduced in abundance and aligned in discontinuous patches
along the MZ sinus (Fig. 8B lower panel). In summary, with age there are several
disruptions in the positioning of cells specific to the MZ region, including the MAdCAM1+ sinus lining cells, MMM, and MZM. It appeared that with age the variability in MZM
was greater than that seen in the MAdCAM-1+ cells and MMM. The degree of alteration
in the MZM population within individual old animals was next assessed. MZM bind and
phagocytize blood-borne bacteria (7, 20), thus changes in the number of MZM with age
can affect the clearance of blood-borne bacteria as less MZM are available to
phagocytize.
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Figure 7. Morphological comparison of disrupted MAdCAM-1+ MZ sinus lining
cells in young and old mice. Representative photos are shown of frozen sections (68µm) stained for MAdCAM-1+ MZ sinus lining cells. (A) Left are representative images
(25x tiled magnification) taken from cross sections of whole mouse spleens with the
MAdCAM-1+ MZ sinus lining cells (purple) observed encircling numerous white pulp
areas. Images to the right (50x magnification) are the MAdCAM-1+ MZ sinus lining cells
of one white pulp area from a representative young (top) and old (bottom) mouse spleen..
(B) Relative linear proportion of disrupted MAdCAM-1+ cells in five young mice (2-3
mo, filled circles) and five old mice (18-23 mo, open squares). Each symbol indicates an
individual animal. The horizontal bars indicate the average and the SEM for each group.
p = 0.0001 determined by unpaired t-test
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Figure 8. Immunofluorescence of cellular compartments of the MZ region of young
and old mice. Representative photos are shown of frozen sections (6-8 microns) stained
for cells within various compartments of the MZ and analyzed by confocal microscopy
(all images taken at 50x magnification). (A) The continuous, tight ring of MAdCAM-1+
MZ sinus lining cells (red) typical of young and the diffused distribution observed in old
mice (examples from 2 mice of each age). Young MOMA+ macrophages MMM (green)
contrast with aged MMM which appear diffuse and infiltrated into the white pulp in old
tissue. Right panels show representative photos of isotype controls. (B) Shows a
representative example of the changes in distribution of MZM (indicated by staining for
MARCO (red) and SIGN-R1 (green)) found in spleens of many old mice. MZM showed
a continuous line encircling the white pulp in young animals in contrast to a patchy,
discontinuous distribution in many old mice. Right panels show representative photos of
isotype controls.
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A reduction in MZM in the spleens of old mice revealed by immunocytochemical
staining
Sections of young and old spleens were stained using antibody to MARCO
(brown) to mark MZM and antibody to MAdCAM-1 (blue) to mark the MZ sinus lining
cells. Figure 9 top panel shows the typical, consistent pattern observed in young spleens:
the MZM population was present in a continuous line of cells adjacent to the sinus lining
cells. However, the distribution of MZM in spleens of old mice was highly variable,
ranging from a young-like distribution of MZM to negligible stain for MZM. Many
spleens from old mice had notably decreased staining for MARCO (Fig. 9A middle
panel, representative of intermediate reduction). In these spleens, the expression of
MARCO was localized in patches rather than in a continuous line of cells around the MZ
sinus. A semi-quantitative scoring was devised in order to compare the MZM
distribution in young vs. old spleens. For each spleen, four well oriented white pulp areas
were graded “blind” for (1) the relative abundance of MARCO + MZM present and (2) the
continuity of MARCO+ MZM positioning around the MZ sinus (detailed in Materials and
Methods). Scores ranging from 1-3 were given for each criterion graded (worst to best;
Fig. 9A shows representative tissue sections for each score). An average of scores was
calculated and shown for individual animals (Fig. 9B). Expression of MARCO+ MZM
showed a statistically significant decrease in old tissue compared to young (n = 13 young
and n = 15 old, p = 0.0012). Using serial sections, immunocytochemical staining for
SIGN-R1, although less intense than for MARCO, also reflected reduced abundance and
patchy pattern (representative examples in Fig. 8B middle panel and data not shown)
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confirming that reduction of MARCO expression reflected a decreased presence of
MZM.
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Figure 9. Semi-quantitative assessment of MZM disruption in spleens from old
mice. (A) Immunocytochemistry of frozen sections (6-8 microns) stained to reveal
MAdCAM-1+ MZ sinus lining cells (blue) and MARCO+ MZM (brown). Left panels are
images taken at 10x and right panels are images taken at 50x magnification. MZM were
semi-quantified for the (1) abundance of MARCO + stain present and (2) the continuity of
MARCO+ MZM positioning around the MZ sinus. Four separate white pulp areas were
graded “blind” per animal and given a score from 1-3 (worst to best). Shown are
representatives from each grade. Top panel represents a grade of 3 showing the typical
abundant and continuous stain for MARCO+ MZM surrounding the MZ sinuses. The
middle panel corresponds to a grade of 2 showing moderate abundance of MARCO+
MZM that moderately encircled the MZ sinus with patches. The lower panel corresponds
to a score of 1, which equates to low or virtual absence of MARCO + MZM that, if
present, were found in patches along the MZ sinus. (B) Semi-quantitative scoring of
MZM for the criteria above. Each symbol represents an average of the summation of the
four scores for each animal. Horizontal bars indicate the average and SEM for each
group. p = 0.0012 as determined Mann-Whitney test (n = 13 young mice (2-3 mo), filled
circles; n = 15 old mice (18-23 mo), open squares).
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A reduction in MZM in the spleens of old mice revealed by flow cytometry
To further explore the interpretation that MZM appeared reduced in many aged
mice, MZM were quantified using flow cytometry analysis. Many reports agree that
MZM express MARCO and SIGN-R1 (7). Although anti-MARCO antibody worked well
in immunocytochemistry, anti-SIGN-R1 antibody more clearly distinguished a
subpopulation in flow cytometry. MZM comprise a minor subset of dispersed spleen
cells; therefore, another marker was used to aid in gating the population. Published
reports indicate that MZM lack expression of the typical macrophage marker F4/80 (18)
and express negligible CD11b (107). By flow cytometry, the SIGN-R1+ population were
consistently identified within a population of large cells that expressed very low levels of
CD11b (Fig. 10A). Based on previous reports that dextran particles bind to SIGN-R1 and
are rapidly cleared from the blood by MZM (17, 18), FITC-labeled dextran administered
i.v. was used to verify the identity of the SIGN-R1+, CD11b low subset as MZM. Figure
10B shows that the SIGN-R1+, CD11b low cells bound dextran within a short time,
confirming that these cells were MZM. To confirm that the MZM are within the CD11b
low population FACS was used to isolate the CD11b high, CD11b low, CD11b negative
subsets (Fig. 11), which were then H&E stained for morphological examination. The
CD11b low subset contained cells that were large and macrophage like in morphology,
while the cells in the CD11b high subset appeared to be largely neutrophils and cells in
the CD11b negative subset were lymphocytes. Attempts to enrich for MZM via column
isolation were unsuccessful, as the column enrichment population had the same
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frequency of MZM as the unenriched population. Therefore, the frequency and number
of MZM of total splenocytes was determined and reported for individual young versus
old animals. Figure 10C shows that there was a significant decrease in the average
frequency of MZM in old mice when compared to young mice (n = 30 young and n = 22
old, p = 0.0001). Table III shows that the number of MZM in old mice also declines
when compared to young mice. The frequency of MZM in some old mice was equivalent
to the frequency of MZM in young mice. Overall, the results indicate a decline in
frequency and positioning of MZM in the marginal zones of aged splenic tissue. It is
possible that the decrease in MZM frequency with age is due to a decrease in the levels of
the SIGN-R1 receptor; however, there was a significant increase in SIGN-R1 expression
on MZM from old mice compared to young (p = 0.0088) (Fig. 10D). To determine if this
increase in SIGN-R1 is attributed to an increase in MZM size with age, flow cytometry
was used to examine the FSC of MZM in young and old mice. MZM from old mice had
a higher FSC value when compared to young MZM, suggesting that MZM from old mice
are larger in comparison to MZM from young mice, a possible explanation for the
increase in SIGN-R1 expression on MZM from old mice (p = 0.0006) (Fig. 10E).
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Figure 10. Quantitative assessment of the frequencies of MZM in spleens from old
and young mice by flow cytometry. (A) Identification of SIGN-R1+ cells (MZM) in the
CD11b low splenic fraction. Contours shown are representative of young spleen cells.
(B) Contour plots from a separate experiment demonstrating that a majority of the CD11b
low/SIGN-R1+ cells took up FITC-labeled dextran within 45min after i.v. delivery, as
expected of MZM (43). (C) Comparison of the frequencies of MZM present in spleens
from young and old mice. Each symbol represents an individual animal. Horizontal bars
indicate the average and SEM for each age group. Old mice have approximately on
average a 45 percent reduction in MZM when compared to young mice. p = 0.0001
determined by Mann-Whitney test (n = 30 young mice (2-3 mo), filled circles; n = 22 old
mice (18-23 mo), open squares). (D) Comparison of the MFI of SIGN-R1 of MZM from
young and old mice (p = 0.0088). (E) Comparison of the forward scatter of MZM from
young and old mice (p = 0.0006). Data presented in (D) and (E) are represented using the
ratio of sample value over the average value of all young mice taken within each
experimental group. Data is expressed as mean ± SEM and are representative of four
separate experiments (n = 10 young mice (2-3 mo); n = 10 old mice (19-23 mo).
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Figure 11. FACS cell sort of CD11b positive and negative populations. FACS was
utilized to separate the CD11b high, low, and negative populations (represented in the left
image as P2-P7; P2 = lymphocyte fraction, P3 = the CD11b low fraction, P4 = CD11b
high fraction, P5 & P = 7 cell doublets, P6 = large macrophages) for visualization of cell
morphology. The cells were cytospun onto microscope slides and H&E stained.
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Decrease in the frequency of MZ B cells in old mice
Knowing that MZM have a direct interaction with MZ B cells I next determined if
there were differences in the MZ B cell compartment with age. For flow cytometry,
gating on MZ B cells was adapted from Won et al. (105). Spleen cells were initially
gated on the B220+, CD23- population followed by gating on the CD21/35 high and IgM
high

fraction (Fig. 12). The frequency (Fig 13A) and number (Table III) of MZ B cells of

the total B220+ cells was then determined and reported for individual young versus old
animals. Figure 13A shows that there was a significant decrease in the average frequency
of MZ B cells in old mice when compared to young mice (n = 30 young and n = 41 old, p
= 0.0001). Furthermore, as seen with MZM, MZ B cells also have a decline in total cell
numbers in old mice when compared to young mice (Table III). As observed with the
MZM population, the frequency of MZ B cells in some old mice overlapped with the MZ
B cell frequency in young animals. Initially, an increase in MZ B cells was anticipated
with age based on the factors present in age that favor MZ B cell development (69, 70)
(71-74) (75-77), however, results showed that there was a significant decrease in the MZ
B cell pool with age.
Given that the MZ B cell population declines with age I next determined if there
were any alterations to the FO B cell population with age. Using flow cytometry, the
frequency (Fig.13B) of FO B cells of young and old mice was determined. Spleen cells
were gated on the B220+, CD23+ population followed by gating on the CD21/35int and
IgMint/high fraction (Fig. 11). The frequency of FO B cells was determined from the total
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B220+ cells. The data show no differences in the FO B cell pool in young and old mice
(n = 14 young and n = 16 old mice, p = 0.3277) These results support published reports
that the mature B cell (FO B cell phenotype) pool in old mice is similar to that of young
mice (88). The distributions of FO B cells in old mice were also similar to that of young
mice. It has previously been reported that there is a decline in the pre B cell pool in the
bone marrow of old mice; however, no differences were present in the mature B cell
pool in the spleens of young and old mice (89). Using BrdU labeling Johnson et al. later
reported that the production of newly formed immature B cells in old mice is similar to
that of young mice. However, this same study also reported that newly formed immature
B cells of old mice were less frequent in spleens of old mice when compared to young
mice, suggesting that the microenvironment of the aged spleen does not allow for the
homing of newly formed B cells. It has been suggested that the mature B cell pool of old
mice are long lived and newly formed immature B cells of old mice are unable to home
to the spleen because the niche is over crowed and does not require more cells (27). The
frequency of FO B cells determined here in old mice may be a reflection of the long lived
mature B cell population and not a result of newly formed FO B cells as previously
discussed by Johnson et al (89). Therefore, decreases in MZ B cells could also be a
reflection of alterations present in the microenvironment of the MZ region of old mice.
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Figure 12. Representative profiles of MZ B and FO B cells from young and old
mice. Flow cytometry was used to determine MZ B and FO B cell frequencies. The MZ
B cell population was determined by gating on the B220+/CD23- fraction followed by
gating on the CD21/35 high/ IgM high fraction. The FO B cell population was determined
by gating on the B220+/CD23+ fraction followed by gating on the CD21/35 int/ IgM high
fraction.
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Table 3. Number of MZM and MZ B cells in the spleens of young and old mice

Table 3. Representative absolute numbers of MZ B cells and MZM of young and old
mice. Flow cytometry was used to determine MZM and MZ B cell absolute numbers.
Absolute numbers of MZM determined within all viable splenocytes and absolute
numbers of MZ B cells within the B220+ population. **p = 0.0070 ; *p = 0.0081
determined by Unpaired t-test. Data is expressed as mean ± SEM and are representative
of two separate experiments (n = 8 young mice (2-3 mo); n = 4 old mice (19-23 mo).
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Figure 13. Comparison of frequencies of MZ B and FO B cells in young and old
mice. (A) Frequency of MZ B cells within the B220+ population. p = 0.0001 determined
by Mann-Whitney (n = 30 young; n =41 old mice). (B) Frequency of FO B cells within
the B220+ population. p = 0.3277 determined by Unpaired-t test (n = 14 young; n = 16
old mice).

CHAPTER V
THE MICRO-ANATOMICAL FACTORS THAT MAY CONTRIBUTE TO
DECREASES IN MZM AND MZ B CELLS IN OLD MICE
Chapter IV showed that there is a decrease in MZM and MZ B cell frequencies and
numbers with age. However, what causes the decrease in these two important immune
cell type is currently not known. This chapter will explore possible factors that may
contribute to the decline in MZM and MZ B cells with age.
MZM and MZ B cells have a direct physical interaction that when disrupted leads
to their displacement within the spleen (15). Therefore, determining if there is a direct
correlation between the reduction in MZM and MZ B cells observed in old mice could
provide insight for the decreases in both immune cells. Reduction in cell
frequency/number can also be attributed to cell intrinsic or extrinsic factors. The cell
extrinsic factors important for MZM and MZ B cells were examined by looking at the
microenvironmental factors important for the maintenance of these cells as components
of the MZ of the spleen.
The chemokine CCL21 and its receptor CCR7 are important for the localization
of MZM within the MZ (43). Therefore it is possible that changes in either chemokine
and/or receptor with age could account for the decline in the MZM frequency found in
old spleens. The decrease in MZ B cells with age could be due to the inability of MZ B
70
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cells in old mice to be retained in the spleen. The microenvironment of old mice was
examined by determining if it can attract young transferred MZ B cells. Can young
transferred MZ B cells home to the spleens of old mice that have reduced MZM, or do
they aberrantly home to other lymphoid organs, such as the lymph nodes and bone
marrow?
Decrease in the frequency of MZ B cells in old mice correlates with the decrease in
MZM
It is well established that MZM directly interact with MZ B cells via the
scavenger receptor MARCO located on the surface of MZM and an undetermined cell
surface ligand on MZ B cells (22-24). Furthermore Nolte et al. found that in young adult
mice, loss of the B cell population corresponded with loss of MZM (40). Therefore, it is
possible that the decrease in MZM in old mice could correlate with the decline in MZ B
cells also seen with age. The spleens were removed from young and old mice, and 2/3 of
each spleen was prepared for flow cytometry analysis in which both MZM and MZ B cell
frequencies were determined. The remaining 1/3 of the spleen was frozen for
immunocytochemistry staining to assess the MZM qualities described in Figure 9. For
flow cytometry, MZ B cells were gated as shown in Fig 12 (Chapter IV) and MZM were
gated as shown in Figure 10 (Chapter IV). Figure 14A shows a significant reduction in
average frequency of MZ B cells in old vs. young mice (n = 17 old, n = 15 young;
p = 0.0002). Although the average reduction was statistically significant, a wide
variation was again apparent in individual old mice. Some spleens had extremely
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reduced MZ B cells; whereas in other spleens, the MZ B cell frequencies were equivalent
to the mid-range of the young group. Furthermore, the reduction in MZ B cell
frequencies appeared to correlate with reductions in MZM assessed by the semiquantitative tissue scoring method (Fig. 14B, r = 0.6429 and p = 0.0003) or by frequency
determined in flow cytometry analysis (Fig. 14C, r = 0.4930 and p = 0.0320). This
correlation remained present within the correlation pairs of each individual old animal
when the correlation pairs of young animals were removed (Fig. 14B, r = 0.5237 and p =
0.0451; Fig. 14C, r = 0.7076 and p = 0.0330).
Although there is a significant correlation present between levels of MZM and
MZ B cells in both young and old mice, the individual values in Figures 14 B and C can
further be divided into 3 separate groups: Poor, moderate, and good. The poor group
corresponds to low MZM and MZ B cell populations in individual animals, the moderate
corresponds to animals with moderate levels of MZM and MZ B cells, and the good
corresponds to animals with frequencies of MZM and MZ B cells that are at levels
normally observed in young mice. It is possible that at some point all the animals will
fall into the poor group and that the moderate group is a type of biomarker showing the
beginning of the collapse in MZM and MZ B cell populations. We are limited in the data
interpretation because one cannot assess decreases in MZM and MZ B cells in an
individual animal over time, therefore highlighting the importance of this analysis.
The correlation present between MZM and MZ B cells frequencies suggests that
the spleens of old mice with decreased MZM may also show a decline of the MZ B cell
population as less MZM are available to physically interact with the MZ B cells (or vice
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versa). It is possible that MZM do not home to the MZ of old mice because of the
decline in the MZ B cell pool present with age. On the contrary, it is also possible that
MZ B cells do not home to the MZ as a result of the decline in the MZM pool with age.
Therefore, data here suggests that extrinsic microenvironmental factors important for
both MZM and MZ B cells appear to be altered in old mice.
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Figure 14. Comparison of frequencies of MZ B cells in young and old mice and
correlation with abundance of MZM. (A) Frequency of MZ B cells within the B220+
population. The MZ B cell population was determined by gating on the B220 +/CD23fraction followed by gating on the CD21/35 high/ IgM high fraction. Symbols represent
individual mice and the horizontal bars indicate the average and SEM for each age group;
p=0.0002 determined by Mann-Whitney test (n = 15 young; n = 17 old mice). (B)
Pearson correlation analysis was performed on 27 spleens from both age groups shown in
panel A that were also sectioned, stained with anti-MARCO, and scored for MZM
criteria; r = 0.6429 and p=0.0003. (C) Pearson correlation analysis was performed in a
separate experiment to compare frequency of MZ B cells versus frequency of MZM
assessed by flow cytometry; r = 0.4930 and p = 0.0320 on 19 spleens from both age
groups. Symbols in A, B, and C represent young mice (2-3 mo), filled circles; old mice
(18-23 mo), open squares.
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Adoptive transfer of MZ B cells to evaluate extrinsic factors in age for the
maintenance of MZ B cells to the MZ
Decreases in MZ B cells with age can be due to failure of MZ B cells to be
retained in the spleens of old mice. Studies in aged animals have shown that the there is
a gross morphological alteration in lymphoid tissues, including smaller germinal centers
(29), and changes in the T cell rich PALS and MZ (26). Studies discussed earlier have
also reported immature B cells of young mice have a reduced ability to home to the
spleens of old mice when compared to young mice but old donor immature B cells had no
homing defect (27). On the other hand, mature follicular B cells (FOB) homed
appropriately in either young or old recipients. Cells enter the spleen at the MZ; the
difference is that the FOB cells move quickly into the white pulp follicles but the
immature B cells linger in the MZ for a period of further maturation. It has been
suggested that the aged defect is a result of alterations in the MZ microenvironment of
old mice. Therefore, I tested the efficiency of the aged microenvironment to allow
homing of young transferred MZ B cells can home to the spleens of old mice or if they
were found in other lymphoid compartments such as the lymph nodes or bone marrow.
MZ B cell homing to the spleen was examined by injecting total enriched splenic
B cells isolated from young mice (of which MZ B cells were approximately 5%) into
young or old mice (Fig. 15). Mice were sacrificed 6 hrs post injection and the spleens
were harvested for staining of donor cells via flow cytometry. The 6 hr time point was
based on experiments done by Cyster and colleagues for homing of FO B cells to follicles
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(108). Results show a reduced frequency of donor MZ B cells in the spleens of old hosts
compared to young, indicating old mice have reduced MZ B cell homing to the spleen
when compared to young mice (Fig 16A, p = 0.0308) (27). This type of experiment may
suggest that some environmental factor such as a chemokine or its ligand is altered with
age. This analysis was performed in concert with experiments by others in the lab to
assess homing of FO B cells to follicles. Independently, I also examined the FO B cell
population using the antibody staining paradigm adapted from Won et al. (105). My
results showed no statistical differences in FO B cell homing between age groups (Fig
16B), which confirmed the now published work of Minges-Wols et al. from our group
(27).
As previously discussed in the background section of this dissertation, skewing
toward MZ B cell output in old animals might be predicted based on the environmental
conditions that favor MZ B cell development over FO B cell development (69-77). Yet,
data presented in Chapter IV show decreases in MZ B cells in most old mice when
compared to young mice (Fig. 13A). Furthermore, results demonstrate that there is a
direct correlation between the decreases in MZ B cells with the decreases in MZM in
individual old mice. Therefore, it may be possible that MZ B cells are being developed at
normal or increased frequency in advanced age, yet the splenic microenvironment in old
mice does not allow for effective homing to the MZ (in this case because absence of
MZM). Results obtained from adoptive transfer experiments found fewer donor MZ B
cells in spleens of old host mice compared to young host mice. To determine if MZ B
cells in normal, unmanipulated mice could be displaced to other lymphoid organs in age,
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lymph nodes, bone marrow and blood of old mice were examined for MZ B cells and
compared to young mice. Results showed that small populations in 2 of 7 old mice
examined had an MZ B cell phenotype present in the bone marrow (Fig. 18) and lymph
nodes (Fig. 19) (Table IV) that was similar to the MZ B cell phenotype observed in the
spleen (Fig. 17). Young mice had no MZ B cell phenotype present in any of these
lymphoid compartments (Table IV). Donor MZ B cells from young mice into old mice
were also examined in the lymph node of the old and results show that 3 of the 6 old mice
examined had characteristic MZ B cell profiles present in the lymph nodes of recipient
mice (Table V). Furthermore, based on previous reports that dextran particles bind to
MZ B cells and MZM (17, 18), FITC-labeled dextran administered i.v. was used to verify
the identity the MZ B cells (similar to the prior study done in Chapter IV, Fig 9B) .
Figure 18 (lower left panel) shows that the MZ B cells bound dextran within a short time,
confirming that these cells were MZ B cells.
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Mature splenic B cells (including
MZ B cells) were isolated from
young C.B17 mice.
B cells were transferred
into young and old BALB/c
mice via tail vein
injections.

After 6 hours mice were sacrificed and
cells from spleens were dispersed and
stained for donor MZ B cells in both
young and old mice.

Figure 15. Adoptive Transfer of B cells
Mature B cells isolated from the spleens of young C.B17 mice (2-3 mo) were injected
into the tail vein of either young (2-3 mo) or old (19-21 mo) BALB/c recipient mice. 6
hours post injection, spleens were removed and antibody staining with an antibody to the
IgMb allotype was performed for donor MZ B cells. C.B17 mice express the IgMb
allotype on the BALB/c background. BALB/c mice are IgMa allotype, so donor B cells
can be distinguished from host B cells.
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Figure 16. Adoptive transfer of B cells from young C.B17 mice into young and old
BALB/c mice. Total splenic B cells, including MZ B cells, were isolated from young
C.B17 mice (that have an IgM/D b allotype) and injected into young and old BALB/c
mice (that have an IgM/Da allotype). Transferred cells were analyzed by flow cytometry
using an antibody to the IgMb allotype that is strain specific and stained for (A) donor
MZ B cells; Unpaired t-test, p = 0.0308 (B) and donor FO B cells; Unpaired t-test, p =
0.2603. Data represent 7 young into young and 6 young into old transfer pairs.
Statistical analysis was performed on the mean of 7 young host and 6 old host  SEM.
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Table 4. Presence of MZ B cells in secondary lymphoid organs of wild type BALB/c mice

Animal

Spleen

Lymph Node

Bone Marrow

Blood

Young

++++
++

-----

---

--

Old

++++
+++

++----

++----

--

Table 5. Presence of MZ B cells in secondary lymphoid organs following adoptive
transfer of mature B cells isolated from BALB/c mice into C.B17 mice

Animal

Spleen

Lymph Node

Young

++++
+++

------

Old

++++
++

+++ --

Table 4 and 5. Evaluation for MZ B cells in secondary lymphoid organs of young
and old mice. In Table IV the spleen, lymph nodes, bone marrow, and blood of 6 young
and 7 old BALB/c mice were evaluated for MZ B cells. Each plus and minus sign
corresponds to an individual mouse. The plus signs indicate presence of the MZ B cell
phenotype and a minus sign indicates an absence. Table V evaluates the presence of the
MZ B cell phenotype in the spleens and lymph nodes of 7 young and 6 old C.B17 mice
after transfer of B cells isolated from young BALB/c mice.
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Figure 17. Representative profile of MZ B population in the spleen of young and
old mice. Shown are contours representative of young or old splenocytes. Top panel is
representative of splenocytes of young mice (4 mo). Lower panel is representative of
splenocytes from an old mice (21 mo). MZ B cell phenotype present in the CD21/35 high/
IgM high fraction of B220+ CD23- splenocytes.
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Figure 18. Representative profile of MZ B population in the bone marrow of young
and old mice. Shown are contours representative of young or old bone marrow cells.
Top panel is representative of bone marrow cells of young mice (4 mo). No MZ B cell
phenotype was present in the CD21/35 high/ IgM high fraction. Lower panel is
representative of bone marrow cells from an old mice (20 mo) that reveals a MZ B cell
like phenotype in the CD21/35 high/ IgM high fraction. Normal MZ B cell flow profiles of
same mouse (young and old) in Fig. 17.
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Figure 19. Representative profile of MZ B population in the lymph node of young
and old mice. Shown are contours representative of young or old lymph node cells.
Frequency of MZ B cells was determined within the B220 + population. The MZ B cell
population was determined by gating on the B220+/CD23- fraction followed by gating on
the CD21/35 high/ IgM high fraction. Top panel is representative of lymph node cells of
young mice (4 mo). No MZ B cell phenotype was present in the CD21/35 high/ IgM high
fraction. Lower panel is representative of lymph node cells from an old mice (21 mo)
that reveals a MZ B cell phenotype in the CD21/35 high/ IgM high fraction, which took up
FITC-labeled dextran within 45min after i.v. delivery, as expected of MZ B cells.
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Evaluation of the chemokine CCL21 and its importance for MZM homing to the
MZ
The cell populations that home to the MZ do so as a result of chemotactic factors
that are secreted by neighboring stromal cells (31, 34, 35, 43). I have shown that the
distribution and frequency of MZM appears altered in many old mice. Furthermore,
fewer young MZ B cells appeared to home to the spleens of old mice compared to those
of young mice, suggesting an extrinsic defect that could be related to the reduction of
MZM. One study suggests that MZM home to the MZ in response to the chemokine
CCL21 and to a lesser extent the chemokine CCL19. Ato et al. observed a decrease in
MZM in plt/plt mice, which lack functional CCL21 and CCL19, (43); furthermore, in
vitro migration assays of enriched MZM demonstrated that CCL21 resulted in migration
of MZM(43). Examination of CCL21 at the protein level using anti-CCL21 antibody
was revealed on splenic tissue sections (Fig. 20A). CCL21 is secreted by the stromal
cells important for T cell homing to the PALS of the spleen (43). Results from young (n
= 7) tissue sections revealed an abundance of CCL21 present in the PALS (T cell regions
of the white pulp areas) (Fig. 20A, top and middle panels). CCL21 was detected in 85%
of the PALS regions examined in the tissues from 7 young mice (Table). However, in
splenic tissue sections of old mice (n = 7) (Fig 20A, bottom panels) CCL21 appeared to
be absent in 55% of the PALS regions examined (Table). CCL21 was also present in the
bridging channels of splenic tissue of both young and old mice (Fig. 20A, top right
panels).
CCL21 was also evaluated in the MZ areas of splenic tissue from young and old
mice to determine if present near MZM. CCL21+ protein was observed to localize in
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clusters adjacent to the outer edge, but not encompassing the MZ in 3/7 young mice
examined. CCL21was also observed in clusters adjacent to the outer edge of the MZ in
3/7 old mice examined. To determine co-localization of CCL21 on MZM, anti-MARCO
antibody was used to reveal the MZM (Fig. 20B). Results revealed that there was no colocalization of CCL21 on MZM in splenic sections from young and old mice. Results
also showed that animals with poor MARCO+ MZM (2 old mice) appeared to have a
heightened CCL21protein in the spleen (Fig.20 C); however, in this figure it was difficult
to determine the amount of CCL21+ PALS/total PALS, CCL21+ protein adjacent to the
outer edge of the MZ, and CCL21+ bridging channels/total bridging channels in these
splenic tissue sections.
To determine if there were differences in mRNA levels of CCL21 in the spleens
of young and old mice, spleens were isolated and homogenized and quantitative RT-PCR
was performed. Results showed no significant differences in CCL21 mRNA between
young and old spleens (p = 0.4234 as determined by Mann-Whitney test; n = 9 young; n
= 8 old) (Fig.21). For some individual animals stained for CCL21 at the protein level, the
level of mRNA was also determined. Results show no definitive correlations.
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Figure 20. CCL21 distribution in spleens from young and old mice. (A) Sections
are stained with antibodies specific for MAdCAM1+ MZ sinus lining cells (green) and
the chemokine CCL21 (red). Confocal microscopy was used to reveal localization of
CCL21, which is found in the T cell rich PALS region of the white pulp follicle, bridging
channels, and around the outer edge of the MZ. Top panel shows the distribution of
CCL21 in young splenic sections from 2 separate animals (top right and left) 25x tile 6x6.
Middle panel shows 2 separate MZ and white pulp follicles from 1 representative young
mouse (25x). Bottom panel shows the distribution of CCL21 in old splenic sections from
2 separate animals (lower right and left) 25x tile 6x6. (B) Sections are stained with
antibodies specific for MARCO (green) and the chemokine CCL21 (red). Top panel
shows the distribution of CCL21 in one young splenic section (top left, isotype control
top right) 25x tile 6x6. Bottom left panel shows the distribution of CCL21 in one old
splenic section 25x tile 6x6 (bottom left, isotype control bottom right). (C) Top and
bottom panels are representatives of 2 separate splenic sections from old mice. MARCO+
MZM in both mice have a poor distribution and CCL21 appears to be abundant.
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Table 6. Presence of CCL21 in Splenic Sections from Young and Old mice
+
Animal CCL21+ PALS/Total PALS CCL21 Protein Adjacent
to
Outer
Edge of MZ
Number

CCL21+ Bridging Channels/
Degree of MARCO
Total Bridging Channels

Y-330

3/3

No

Y-331

4/5

Yes

Y-334

3/3

Yes

Y-335

5/5

No

2/2
2/3

Y-462

Yes

4/4

* Y-469

3/4
1/2

No

1/1

Good MARCO

* Y-470

3/4

No

1/1

Good MARCO

O-332

1/3

Yes

2/2

O-333

1/4

No

0/0

O-336

1/3

No

0/1

O-450

1/4

Yes

0/0

* O-471

3/3
?
2/3

No
Yes
?

3/3
0/0

* O-472
* O-473

0/0
0/0

?

Good MARCO
Poor MARCO
Poor MARCO

Table 6. Distribution of CCL21 protein in splenic sections of young and old mice.
The spleens of 7 young and 7 old BALB/c mice were evaluated to determine differences
in CCL21 protein throughout the spleens. The number of CCL21+ PALS/Total PALS,
the presence of CCL21+ protein adjacent to the outer edge of the MZ, the number of
CCL21+ bridging channels/ total bridging channels, and the amount of MARCO (where
appropriate) was evaluated between age groups. Splenic tissue sections were stained to
reveal either CCL21 and MAdCAM-1+ MZ sinus lining cells or CCL21 and MARCO+
MZM (*).
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Figure 21. Expression of CCL21 protein and mRNA Quantitative RT-PCR on
spleens from young (2-4 mo) and old (18-23 mo) mice showed no statistical differences
between age groups. p = 0.4234 as determined by Mann-Whitney test (n = 9 young mice;
n = 8 old mice).
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CCR7 levels in young and old MZM
The receptor for CCL21 is CCR7, which is expressed on MZM (43). In order to
determine if CCR7 receptor levels on MZM are altered with age, the flow cytometry
staining paradigm developed for MZM identification was implemented (Fig. 22). The
percentage of MZM that were CCR7+ was determined for both young and old mice, and
results showed that there was a decrease in the percentage of CCR7+ MZM in old mice
when compared to young mice (Fig. 24). Yet, it is of interest to note that although there
is a decrease in the percentage of CCR7+ MZM in old, the overall expression of CCR7+
MZM of both young and old mice was low compared to what is normally observed with
T cells (Fig. 23). Work by Ato et al. first revealed that MZM express CCR7 weakly
compared to naïve T cells and DCs (43). This was determined by staining splenocytes
isolated from dextran-FITC injected mice (used to identify MZM) with a recombinant
CCR7 ligand, CCL19-Ig chimeric protein, which was generated by Manjunath et al.
(109). CCL19 like CCL21 is a chemokine for the CCR7 receptor (43). MZM were
identified as FITC+ SIGN-R1+ by flow cytometry and the level of CCR7 was determined
from this pool and observed to be low (43).
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SIGN-R1-ALEXA-647

Figure 22. Flow cytometry profiles reveal the percentage of CCR7+ MZM of young
and old mice. The MZM population is determined from the CD11b low SIGN-R1+
fraction and the percentage of CCR7 is revealed in the PE channel. Top panels are the
isotype control for CCR7 and representative profile from young mouse depicting the
CCR7 positive MZM. The lower panels are the isotype control for CCR7 representative
MZM profile and representative profile from an old mouse depicting the CCR7 positive
MZM.
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Figure 23. Flow cytometry profiles reveal the percentage of CCR7+ CD4+ T cells of
young and old mice. The CD4+ population is determined from viable lymphocyte
fraction and the percentage of CCR7 is revealed in the PE channel. Top panel is a
representative profile of the isotype control for CCR7. Middle panel is a representative
of young profile and the lower panel is representative of old profile.
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Figure 24. Percentage of CCR7+ MZM of young and old mice. The percentage of
CCR7+ MZM in young and old mice was determined by flow cytometry. Data show that
old mice have significantly lower percentages of CCR7 expressed on MZM when
compared to young mice. p = 0.0314 as determined by Unpaired t test (n = 6 young
mice; n = 7 old mic

CHAPTER VI
EVALUATION OF THE FUNCTIONAL DIFFERENCES BETWEEN
MZM OF OLD AND YOUNG MICE
Data presented in Chapter IV revealed that there are decreases in the MZM pool
with age. I next wanted to determine if loss in cell number alone or a combination of loss
of number and decrease in cell function may contribute to the age related decline in the
TI immune response. The MZM from old mice were evaluated to determine if they are
functionally different compared to MZM of young mice by measuring differences in
phagocytosis by MZM.
In order to measure the phagocytic ability of MZM in young and old mice a
number of experimental approaches were examined. The first experiment aimed to
examine the functional differences of MZM in vivo through intravenous delivery of
dextran. Analysis was done via confocal microscopy and flow cytometry. The second
series of experiments aimed to measure the phagocytic function of MZM in vitro after
treatment with pHrodo ™ S. aureus bioparticles (pHrodo); analysis was done via flow
cytometry. Techniques established from the first two series of experiments helped build
the next series of studies. In these last experiments, MZM were successfully targeted for
measurement of phagocytosis and live visualization of phagocytosis by MZM was
revealed using a Leica TC5 SP5 confocal microscope.
95
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Functional differences in capture of blood-borne dextran particles by MZM in old
mice
Since an important function of MZM is the clearance of blood-borne antigens, I
asked whether reduced capture of blood-borne antigen would be a consequence of the
changes in MZM with age. MZM have been shown to decrease in age; however, whether
this decrease in cell frequency/number implied reduced cell function needed to be
clarified. SIGN-R1 [homologue of human DC-SIGN (16)] binds the capsular
polysaccharide of Streptococcus pneumoniae and also to the polysaccharide dextran (1720). For these experiments the rapid, in vivo binding of FITC-labeled dextran to SIGNR1 was used to mimic antigen (18, 43). Dextran-FITC was administered i.v. into tail
veins of young and old mice (Fig. 25). It has been previously shown that dextran binds
MZM in tissue in as early as 45 min and at later time points dextran is no longer
visualized on MZM (18). After 45 min, animals were sacrificed and the spleens removed
and frozen in O.C.T for visualization of dextran binding to cells in tissue sections.
Spleen sections were stained with anti-MAdCAM-1 to distinguish the MZ sinus lining
cells as a landmark. To confirm that dextran+ macrophages were MZM, tissue sections
were stained with anti-MARCO antibody for the expression of MARCO, found on the
surface of MZM. (Fig. 26A). As reported by Ato and colleagues for young mice (43),
after 45 min dextran binds to MZM, appearing as a continuous ring on the outer edge of
the MZ sinus. Confocal microscopy revealed a clear “ring” of bound dextran-FITC
adjacent to the MAdCAM-1+ cells in the MZ of young spleens (Fig. 26B). In contrast,
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the tissue sections from old spleens had less bound dextran-FITC in the MZ when
compared to the young tissue and showed a patchy deposition similar to
immunocytochemistry staining for MARCO (Chapter IV, Fig. 9A). This patchy
distribution could be a reflection of fewer MZM present in the spleens of old mice and
less indicative of an alteration in cell function.
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Experimental Design:
100 µg Dextran –
FITC was
administered via tail
vein into young and
aged mice.

After 45 min
mice are
sacrificed

Confocal
Microscopy

Flow
Cytometry

Figure 25. Intravenous injections of dextran-FITC into young and old mice.
Dextran-FITC was administered i.v. into young and old mice. After 45 min, mice were
sacrificed and spleens were removed. One half of the spleen was frozen in O.C.T for
sectioning to evaluate the localization of dextran-FITC in the MZ via confocal
microscopy. The second half of the spleen was dispersed and single cell suspensions were
stained with anti-CD11b and anti-SIGN-R1 antibodies for flow cytometry analysis of the
percent of dextran positive MZM.
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Figure 26. Binding of dextran by MZM of old versus young mice. Confocal images
of frozen splenic sections harvested 45 min after dextran-FITC (green) was given
intravenously to female BALB/c mice. (A) Co-localization of dextran (green) with
MARCO+ MZM (red) is observed as yellow after staining dextran positive tissue from a
representative young (top) and old (bottom) mouse. (B) Photos show typical deposition,
representing 2 of 18 young (2-3 mo, top panels) and 2 of 16 old (18-23 mo, bottom
panels) mice. In the spleens of most old mice, uptake of dextran appeared in
discontinuous patches along the outer edge of the MZ sinus. MAdCAM-1+ MZ sinus
lining cells (purple) are stained as a landmark. (C) Representative young (top) and old
(bottom) splenic sections from PBS injected mice.
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Measuring dextran positive MZM by flow cytometry – pitfalls and potentials
To determine if MZM of old mice are less efficient at capturing dextran,
differences in the percentage of dextran positive MZM of young and old mice was next
determined by flow cytometry. As described above, mice were injected i.v. with dextranFITC in the tail veins and after 45 min, 1/2 of each spleen was dispersed for flow
cytometry analysis. The MZM population was identified in the CD11b low and SIGNR1+ fraction and the percentage of MZM that were dextran+ was revealed in the FITC
channel. PBS (no fluorophore) was delivered i.v. into the tail veins as a control. From
the flow cytometry profiles of PBS injected mice, it was determined that MZM have a
high level of autofluorescence in the FITC channel (Fig. 27). Based on this high level of
background, the percentage of dextran+ MZM could not be adequately determined in
young and old mice.
In order to be able to use flow cytometry to determine binding of dextran-FITC by
MZM, this background autofluorescence needs to be corrected. To determine if the
experimental design contributed to the high level of background fluorescence, the method
of i.v. delivery of dextran-FITC or PBS delivery was first examined. Delivery of
dextran-FITC and PBS into the tails veins of mice, which requires warming the mice, was
compared to intraocular delivery of dextran-FITC and PBS, a different i.v. route that does
not require manipulation. Results were not different between injection routes; therefore,
I conclude that the autofluorescence of MZM in the FITC channel prohibited the
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determination of differences in the percentage of dextran positive cells in young and old
MZM.
To correct for this autofluoresence in the future, either a fluorophore of a higher
emission conjugated to dextran needs to implemented or more precise filters need to be
used that correct for the observed spectral overlap. MZM from PBS injected mice
showed up positive in the dextran-FITC channel; this suggests that the spectral overlap is
occurring with the natural autofluoresent properties of MZM with the low emission FITC
fluorophore conjugated to the dextran. To reveal dextran-FITC positive MZM
populations by flow cytometry, the use of multiple antibodies of which each is
conjugated to a unique fluorophore is required. Therefore, a precise bandpass filter,
which separates the emission of multiple wavelengths, would be needed to differentiate
the emission of the cells autofluoresence from the FITC fluorphore emission.
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Figure 27. Flow cytometry of MZM from young and old mice injected with
dextran-FITC. Dextran-FITC was delivered i.v. in the tail vein of young and old mice
and analyzed for the percent of dextran-FITC positive MZM. Top panel shows a
representative flow cytometry profile of PBS injected control, the middle panel represents
a dextran-FITC injected young, and bottom panel represents a dextran-FITC injected old
mouse. Far right top panel shows the MFI of PBS injected controls, which are similar to
dextran-FITC injected mice (far right middle panel).
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Evaluation of functional differences in the phagocytosis of pHrodo bioparticles by
MZM in old and young mice using flow cytometry
I next aimed to test the phagocytosis of MZM between age groups using a pH
sensitive antigen that emits fluorescence in a higher channel (PE) using flow cytometry.
Although MZM are known for their highly phagocytic properties (9), it is not known if a
decline in the phagocytic function of MZM from old mice, compared to young,
contributes to decreased TI immune response in age. Here, pHrodo ™ S. aureus
bioparticles (pHrodo) were used to specially aim to measure the phagocytosis of MZM.
pHrodo consists of killed S. aureus conjugated to a fluorescent compound that is pH
sensitive and emits fluorescence only under acidic conditions. Binding of antigen by
macrophages initiates phagocytosis, which consists of three essential compartments: early
endosome, late endosome, and lastly, the lysosome. These separate phagocytic
compartments each have a specific pH (56). Progression through early endosome (pH 6),
late endosome (pH 5.5), and the lysosome (pH 4) leads to decreases in pH. pHrodo
bioparticles start to emit florescence at a pH of 6 and hit peak fluorescence at a pH of 4
(56, 58). The fluorescence of pHrodo can be detected by a microplate reader, flow
cytometer, or confocal microscope.
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Phagocytosis of pHrodo bioparticles by a heterogeneous culture of adherent
splenocytes measured via a microplate reader
To measure phagocytosis of pHrodo by the manufacturer’s suggested protocol, a
microplate reader was first used. The concentration recommended by the manufacturer is
100µg of pHrodo for 100,000 cells (Invitogen). Splenocytes were harvested and 1 x 106
cells/well were cultured onto 96 flat bottom well plates for 1 hr. The adherent cells
(macrophages) in the spleen make up approximately 10% of the total splenocyte
population. Therefore, non-adherent cells were removed to yield approximately100,000
cells/well. 100µl containing 100µg pHrodo were added per well and allowed to incubate
for 2 hrs at 37 C. The 96 well plates were loaded in replicates of three for each animal as
follows: cells + pHrodo, cells only, pHrodo only, and media only negative control. After
2 hrs the samples were placed in a microplate reader. Excitation of pHrodo occurred at
550 nm and emission at 600 nm. The ratio of net experimental phagocytosis over net
baseline phagocytosis x 100% gives a percentage of the net effect of phagocytosis of
pHrodo by the adherent cells (Fig. 28). To calculate the net baseline phagocytosis, the
mean of the three replicates of cells only and the mean of the three replicates of pHrodo
only were first added. The mean negative control value (media only) was then subtracted
from this value. The net experimental phagocytosis was calculated by subtracting the
mean negative control value from the mean of cells + pHrodo.
Results showed no differences in the net effect of phagocytosis between old and
young total adherent cells (Fig. 28) (n = 3 mice for both young and old, p = 1.0000).
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These results did confirm that the pHrodo bioparticles work as the manufacturer
suggested, but was not sufficient for specifically targeting MZM.
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Table 7 . Avg MFI of adherent splenocytes treated with or
without pHrodo for 2hrs via microplate
Animal

pHrodo & Cells
cells
only

Y-1
Y-2
O-1
O-2
O-3

2685
1537

84
90

2045
1993
1971

105
87
86

pHrodo
only
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only

1657
1405
1795
1785
1815

90
90
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93
90

Figure 28. Percent net effect of pHrodo by adherent splenocytes from young versus
old Mice. Results are reported by taking the ratio of net experimental phagocytosis x
100% over net baseline control phagocytosis to give a percentage of the net effect of the
adherent cells.
Net experimental phagocytosis x 100%
% Net Effect

=

Net baseline control phagocytosis

The horizontal bars indicate the average and the SEM for each group. p=1.0000
determined by Mann Whitney test (n=3 for each age group; young mice (2-3 mo), filled
circles; old mice (18-23 mo), open squares). Bottom table represents raw MFI values
obtained from pHrodo + cells, cells only, pHrodo only, and media only of representative
young and old animal samples.
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Establishment of concentration, time and inhibitor of pHrodo treatment in vitro for
flow cytometry analysis
In order to use flow cytometry to measure phagocytosis of pHrodo the
concentration, time, and inhibitor of pHrodo needed to be determined. The manufacturer
recommends 100µg of pHrodo for 100,000 cells, which are adhered to a 96 well plate
that measures phagocytosis of pHrodo directly in the wells. For flow cytometry, single
cell suspensions are run through the flow cytometer in order to detect the amount of
fluorescence associated with the cell. The aim of these experiments was to specifically
measure the amount of pHrodo phagocytized by MZM; therefore, MZM flow cytometry
staining as well as pHrodo treatment was implemented. In order to stain for MZM using
cells treated with pHrodo, the cells needed to be adhered to a larger surface than the 96
well plates to allow for collection of the cells. 35 mm culture plates were used and the
optimal concentration of pHrodo for flow cytometry detection was determined to be
125µg of pHrodo for approximately 200,000 adherent cells (Fig 29 and 30). The
suggested time for pHrodo incubation is 2hrs. Phagocytosis, as measured by the use of
latex beads, has been well established to occur in 30 min (55). The 30 min time point for
pHrodo, measured by flow cytometry, gave variable MFI when compared to the 2hr time
point (Fig. 30). It appears that after 30 min at increasing concentrations (62.5-1000µg),
adherent cells are not able to take in additional pHrodo and the MFI decreased to lower
values. The use of beads to quantify phagocytosis does not distinguish between beads
that bind on the cell surface from beads that are endocytosed. pHrodo reveals
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phagocytosis after the phagosome has been endocytosed, which may require additional
time to see its fluorescence via flow cytometry. Therefore, it is possible that MZM have
a threshold for the amount of pHrodo that can be taken in by the cell before additional
bioparticles can be bound and endocytosed.
An effective control for pHrodo would be one that would inhibit its phagocytosis
and therefore prove its efficacy. To determine the best control for pHrodo reduced
temperatures (-20C) was initially used to inhibit phagocytosis and found to be an
ineffective, since a positive fluorescence was still detected (data not shown). Subsequent
experiments found that 1.0 % sodium azide, an electron transport chain inhibitor, was
found to reduce the phagocytosis of pHrodo. These series of experiments discussed in
this section revealed the best concentration, time of pHrodo incubation, and inhibitor to
pHrodo in vitro for flow cytometry analysis.
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Experimental design of pHrodo treatment for flow cytometry analysis
125µg/200,000 adherent
splenocytes of pHrodo
added for 2 hrs at 37C.

Cells were collected using a
policeman scraper, stained to
identify MZM,
and analyzed using
FACScanto.
Heterogeneous
suspension of fresh
splenocytes.

Figure 29. Experimental paradigm of pHrodo treatment for flow cytometry
analysis. Heterogeneous suspension of fresh splenocytes from young and old mice were
allowed to adhere onto 35 mm culture plates for 1hr in RPMI + 10% FBS. Non-adherent
cells were removed and 125µg of pHrodo at a volume of 125µl was added to
approximately 200,000 adherent splenocytes and allowed to incubate for 2 hrs at 37C.
After 2 hrs cells were gently scraped and stained with antibodies for identification of
MZM by flow cytometry.
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Figure 30. Titration of pHrodo for use in flow cytometry. Top panel shows that at
increasing concentrations of pHrodo incubated at 37 C for 30 min, there is a gradual
increase in the MFI with a threshold at 500 µg/ml/200,000 splenocytes. Bottom panel
demonstrates that after 2 hr incubation with pHrodo, fluorescence can be detected starting
at 60 µg/ml/200,000 splenocytes and stays steady with increasing concentrations. Media
only controls at both 30 min and 2hrs auto-fluoresced at an MFI of near 500.
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Phagocytosis of pHrodo bioparticles revealed by flow cytometry
To evaluate the differences in phagocytosis of pHrodo by MZM from young and
old mice, differences in the percentage of pHrodo positive MZM between age groups
were aimed to be determined by flow cytometry. As previously mentioned, pHrodo is
killed Staphylococcus aureus conjugated to a dye that emits fluorescence under acidic
conditions. MZM have been shown to bind Staphylococcus aureus via the surface
receptor MARCO (15). Adherent splenocytes from young and old mice were cultured
and 125 µg of pHrodo was administered for 2 hrs at 37 C. Adherent cells were collected
and stained to identify MZM. Initially MZM were stained using the antibodies to CD11b
and MARCO. Notably, a 2-3 fold increase in the percentage of CD11b low MARCO+
cells after pHrodo treatment was found compared to media treated controls that exhibited
typical MARCO+ MZM phenotypes (Fig. 31). This observation supports prior reports
that have shown after LPS treatment, MARCO was upregulated on red pulp macrophages
(110, 111). Therefore, I think that the 2 hr incubation with pHrodo induced expression of
MARCO on red pulp macrophages and using the antibody to MARCO to identify MZM
will not differentiate MZM from the red pulp macrophages. Recent work by Kirby et al.
examined if non-lymphoid splenocyte populations including red pulp macrophages,
neutrophils, and dendritic cells upregulate SIGN-R1 after antigen exposure similar to that
which is seen with MARCO (6). Mice were infected with Leishmania donovani to
specifically deplete MZM and were subsequently infected S. pneumoniae to determine if
other splenocytes upregulated SIGN-R1 to bind and clear S. pneumoniae. Their results
showed minimal expression of SIGN-R1 on other splenocyte populations after infection
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with S. pneumoniae in Leishmania infected mice. As a result of these published findings,
I elected to use the antibodies to CD11b and SIGN-R1 to identify pHrodo+ MZM.
However, an increase in CD11b low SIGN-R1+ cells after pHrodo treatment was
observed in both young and old mice after incubation with pHrodo for 2hrs in vitro from
splenocytes obtained from wild type BALB/c mice (Fig. 32). Due to this increase
observed in the CD11b low SIGN-R1+ cells after pHrodo treatment, it is unclear if MZM
are exclusively responsible for the phagocytosis of the pHrodo bioparticles. It is possible
that the data obtained via flow cytometry includes other CD11b low splenocytes that
have upregulated SIGN-R1 after encounter with antigen.
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Figure 31. Representative flow cytometry profile of MARCO upregulation on
splenic adherent cells upon treatment with pHrodo. Flow cytometry was used to
distinguish pHrodo+ MZM from cultured adherent splenocytes from young and old mice
after 2 hr in vitro pHrodo treatment. MARCO+ MZM were defined using the antibodies to
CD11b and MARCO. The CD11b low fraction was gated from all viable cells in the
spleen and the MZM population revealed in the CD11b low and MARCO + fraction. The
top panel shows media only controls with normal levels of CD11b low MARCO + MZM
(18.0%); the lower panel shows > 3 fold increase in CD11b low MARCO+ after pHrodo
treatment and approximately equal decreases in the CD11b low MARCO negative
quadrant.
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Figure 32. Representative flow cytometry profiles of SIGN-R1+ MZM upon
treatment with pHrodo. Flow cytometry was used to measure phagocytosis of pHrodo
by MZM from whole cultured adherent splenocytes isolated from young and old mice
after 2hr in vitro pHrodo treatment. SIGN-R1+ MZM were targeted using the antibodies
CD11b and SIGN-R1. The CD11b low fraction was gated from all viable cells in the
spleen and the MZM population revealed in the CD11b low and SIGN-R1+ fraction. Top
panels are media treated control and pHrodo treated sample of one representative young
mouse and bottom panels are media treated control and pHrodo treated sample of one
representative old mouse.
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Summary of the functional studies on MZM (part I)
From the initial series of experiments, confocal microscopy revealed that less
dextran-FITC was bound in the MZM tissue compartments of old mice when compared
to young mice. Yet, it remains to be clarified if the presence of less dextran-FITC on
MZM is a result of fewer MZM present in the old tissue or the result of an alteration in
MZM function with age. Flow cytometry studies attempted to quantify the percentages
of dextran+ MZM of young and old mice but proved to be limiting with the current
instrument filters. Phagocytic differences of young and old MZM using flow cytometry
was attempted using pHrodo bioparticles, but this also proved to have limitations. This
time, the fluorescence of pHrodo was clearly higher than the control background, but
whether the pHrodo + phagocytic cells were exclusively MZM was unclear. The next
series of experiments built on the positives gained from these initial experiments to
directly determine whether MZM from old mice differ in function when compared to
young mice.
Measuring the phagocytic differences of MZM from young and old mice using live
cell confocal microscopy
To quantify and visualize the phagocytosis of pHrodo by MZM, MZM treated
with pHrodo were examined by confocal microscopy. MZM make up 1-2% of total
splenocytes and to target this rare population of macrophages for functional analysis can
be difficult. Immunocytochemistry showed that MZM bind dextran-FITC in vivo in both
young and old mice (Fig. 26). Therefore, I next sought to determine if I would be able to
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use this experimental approach to mark MZM and distinguish these cells via confocal
microcopy in culture. Studies done in the last section also established the in vitro
culturing and treatment of pHrodo on adherent splenocytes. Once adhered in culture,
dextran+ MZM can be co-cultured with pHrodo and the dextran+pHrodo+ MZM can be
visually identified by Leica TCS SP5 confocal microscopy (Fig. 33). The Leica TCS SP5
confocal microscope, like the flow cytometer, uses lasers to excite fluorophores;
however, the Leica TCS SP5 uses a prism to separate the fluorophore emission. This use
of a prism generates a single peak of intensity that is only seen by the flow cytometer
through the use of precise optical filters. Therefore, using the Leica TCS SP5 confocal
microscope the FITC fluorophore can be differentiated from the natural autofluoresence
of the MZM. The phagocytosis of pHrodo (and in turn dextran) can be quantified on a
per cell basis using image analysis.
Briefly, results by confocal microscopy revealed fields of dextran+cells,
pHrodo+cells, and a small fraction of dextran+pHrodo+ MZM observed by confocal
microscopy. Each image taken of these fields targeted the dextran+pHrodo+ MZM (due
to the small frequency of MZM present in culture) while including the single positive
dextran and pHrodo cells. The pHrodo + cells showed numerous pHrodo + phagocytic
compartments within each cell – confirming visually that pHrodo was being efficiently
phagocytized. A phagocytic compartment is defined as any one compartment of the
endocytic pathway: early endosome, late endosome, or the lysosome. Since pHrodo starts
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to emit fluorescence at a pH of 6 it is difficult to discern the different compartments of
the endocytic pathway.
By image analysis the mean fluorescence intensity (MFI) of the pHrodo +
phagocytic compartments and the dextran-FITC captured by MZM were assessed per cell
to determine any differences in phagocytic function between young and old MZM. In
addition, the numbers of pHrodo + phagocytic compartments/cell-image were compared
between age groups. Image analysis was also used to determine differences in size of
adherent MZM. Finally, the imaged fields were analyzed for the frequency of pHrodo +
cells of the total dextran+ MZM.
Establishment of the concentration and time of the in vitro pHrodo treatment of
dextran marked MZM
In order to view dextran+pHrodo+ MZM live by confocal, the correct
concentration and time of pHrodo incubation needed to be determined. Splenocytes
obtained from dextran-FITC injected mice were harvested and allowed to adhere onto 4well chamber slides. The surface area of the chamber slides was significantly smaller
than the area of 35 mm culture plates used previously for adherence in the flow
cytometry analysis. Therefore, a series of titrations were performed and plating 4 x 106
splenocytes/well (non-adherent cells were removed to yield approximately 400,000
adherent splenocytes) with 100 µg of pHrodo was determined to be optimal for
visualizing individual pHrodo+ cells by confocal microscopy. Low numbers
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(approximately 100,000/well) of adherent splenocytes took longer to identify
dextran+pHrodo+ MZM and high numbers (approximately 600,000/well) of adherent
splenocytes over saturated the chamber. In addition, pHrodo was examined after
incubation at 1hr, 1.5 hr, 2 hr, and 3 hr. The 1.5 hr time point was sufficient to observe
phagocytic compartments in individual MZM by confocal microscopy and still detect
dextran associated with the MZM. It was found that if tissue processing took more than 6
hr, dextran was no longer observed within MZM (data not shown). To assure effective
dextran injections, half the spleens removed 45 min post dextran injection were saved for
sectioning to once again reveal positioning of dextran to the MZ.
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Figure 33. Experimental paradigm of pHrodo treatment of dextran-FITC marked
MZM. Young and old BALB/c mice were injected with 100 µg of dextran-FITC and
sacrificed after 45 min. The spleens were removed and splenocytes dispersed and adhered
onto 2 ml chamber wells for 1 hr. Non-adherent cells were removed and 100 µg of
pHrodo was administered to approximately 400,000 adherent splenocytes for 1.5 hr.
After 1.5 hr incubation with pHrodo, cells were visualized live via a Lecia TC5 SP5
confocal microscopy.

121
Imaging pHrodo+ dextran+ MZM
Once pHrodo+ dextran+ MZM were identified by confocal microscopy, a
standardized regimen of imaging was captured for analysis using the Lecia TC5 SP5
confocal microscope. For each animal, approximately15 different pHrodo+ dextran+
MZM were identified and imaged. Images taken targeted the pHrodo+ dextran+ MZM,
but also captured single dextran+ and pHrodo+ cells. The images captured of these cells
were taken near the middle of the cell at a thickness of 1 micron. The MFI of dextran and
pHrodo within each MZM was determined using ImageJ software. Gates were drawn
around the perimeter of the MZM and the MFI measured and recorded.
To confirm that images taken near the middle of the cell at 1 micron in thickness
give an accurate representation of pHrodo within the MZM, a series of z-stack
measurements were done. Z-stack measurements are taken by going through a cell slice
by slice from top to bottom. Approximately 34 slices are imaged at 1 micron in thickness
(an adherent macrophage is approximately 8 microns in thickness; therefore there is some
overlap within the corresponding z-stack sections imaged). For each animal, 2 separate
z-stack measurements were done and the MFI of each of the 34 slices was obtained. The
average value of the 34 slices imaged was compared to the MFI obtained by taking an
image near the middle of the cell. Results show that the values were nearly identical
(Table VII); therefore, imaging MZM near the middle of the cell at 1 micron in thickness
gave an accurate representation of the live cell. In addition, images of MZM were
captured at 1, 2, 3, 4, and 5 microns in thickness by opening up the pinhole of the
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microscope. Opening the pinhole of the microscope draws in more light allowing greater
depth of capture of the image. However, imaging the MZM at increasing thicknesses
resulted in decreased resolution and contrast of the cell; therefore, a thickness of 1 micron
was optimal for imaging live MZM.
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Table 8. Avg Z-stack vs standard image of MFI of pHrodo+
phagocytic compartments/MZM

Animal

Z-Stack
Avg

Standard
Image

Y-419
Y-420

268

104

230
109

Y-422
O-421
O-423

560

592

135
522

158
592

Table 8. Values represent the MFI obtained from either the average of 34 images (Zstack) or the MFI obtained when the image is taken near the middle of the cell. Shown
are values obtained from 2 separate experiments.
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pHrodo phagocytic compartments over time
Each MZM imaged contained numerous pHrodo phagocytic compartments at
various stages in the endocytic pathway. To determine if there were drastic changes in
the quantity of phagocytic compartments and the MFI over time, two separate time lapse
experiments for 60 and 120 minute time points (time 0 = pHrodo administration) were
conducted (Fig. 34). Images were taken once every minute for a total of 60 images (for
the 60 minute time lapse) and once every 2 minutes for a total of 60 images (for the 120
minute time lapse). Results show for both the 60 and 120 minute time lapse experiments
there is an initial peak 10 min post pHrodo administration in pHrodo fluorescence within
the MZM before the MFI starts to gradually decline with time.
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Figure 34. The MFI of pHrodo+ phagocytic compartments over time. Top graph
shows the range in MFI of pHrodo + phagocytic compartments in a MZM over 60
minutes. Bottom graph shows the range in MFI in a MZM over 120 minutes. Each
symbol represents an image taken every 5 minutes for the 60 minute time lapse
experiment and every 10 minutes for the 120 minute time lapse experiment.
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Quantification of pHrodo in dextran+ MZM
Results obtained from confocal microscopy revealed numerous pHrodo +
phagocytic compartments within MZM (Fig. 35). To determine differences in the
phagocytosis of pHrodo between MZM from young and old mice, dextran+ pHrodo+
MZM were first distinguished from dextran only and pHrodo only single positive cells.
The MFI of pHrodo from the double positive MZM was then determined. The MFI was
taken to reflect the amount of pHrodo phagocytized. Results showed that the MZM from
old mice had no differences in the amount of pHrodo phagocytized when compared to
MZM from young mice (Fig. 36B) (n = 10 young and n = 9 old, p = 0.2689). To rule out
differences in size of adherent MZM in young versus old affecting the data obtained for
MFI, the area of the MZM from young and old were also determined and found not to be
significantly different between age groups (Fig. 36C) (n = 10 young and n = 9 old,
p = 0.1317). Individual phagocytic compartments were also counted in young and old
MZM. Data show that there were also no differences in the number of phagocytic
compartments between age groups (Fig. 36E) (n = 8 young and n = 7 old, p = 0.5989).
Notably, after imaging numerous pHrodo +dextran+ MZM (15/animal) from both
young and old adherent splenocytes that only a fraction of the imaged adherent cells from
old mice met the criteria for evaluation of phagocytosis by MZM (macrophage in
morphology, dextran+ and pHrodo+) when compared to adherent MZM from young
mice. The young mice had roughly 40% more pHrodo+ dextran+ MZM present in culture
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compared to old mice. These results are consistent previous findings that the
frequency/number of MZM decline with age (Fig. 10; Table III).
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Figure 35. Comparison of the phagocytosis of MZM isolated from old and young
mice. Confocal images of live adherent MZM administered pHrodo for 1.5 hr after
harvested from young and old mice administered dextran-FITC (green) intravenously.
Photos show typical dextran+ pHrodo+ MZM taken live at 5000x magnification at cell
thickness of 1 micron. Photos are representative of MZM isolated from 1 young of 10
(top panels) and 1 of 9 old (bottom panels). Dextran (green) only uptake can be
visualized in the left panels, pHrodo only visualized in the middle panels, and an overlay
of the dextran+ pHrodo+ MZM in the right panels.
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Figure 36. Quantification of pHrodo in dextran + MZM. (A) and (B) Comparison of
the MFI of pHrodo+ phagocytized compartments by MZM from young and old mice.
Using ImageJ software a perimeter was drawn around the area of each MZM analyzed
and the MFI was determined for pHrodo (top graph depicts the raw data from 2 separate
experiments). p = 0.2689, Mann Whitney test; n = 10 young mice (2-3 mo); n = 9 old
mice (19-23 mo). (C) Comparison of the area of adherent MZM from young and old
mice. p = 0.1317, Unpaired t-test; n = 10 young mice (2-3 mo); n = 9 old mice (19-23
mo). (D) and (E) Comparison of the number of phagocytic compartments in MZM from
young and old mice (top graph depicts the raw data from 2 separate experiments). p =
0.5989, Unpaired t-test; n = 8 young mice (2-3 mo); n = 7 old mice (19-23 mo). All data
in figures (B), (C), and (E) are expressed as mean ± SEM and are representative of six
separate experiments.

132
Percent pHrodo+ of the dextran+ MZM
It is possible that the pHrodo + dextran+ MZM of old mice that were evaluated
were from a pool of functional MZM and that non-functional MZM were not imaged
because of their inability to phagocytize pHrodo. To test this hypothesis, I determined
the proportion of pHrodo+ cells of the dextran+ adherent MZM. As previously
mentioned, 15 separate images of pHrodo+dextran+ MZM /animal were captured. Each
of these images contained multiple cells that were both single positive for dextran and
pHrodo or double positive for dextran and pHrodo (Fig. 37A). The ratios of pHrodo+
cells: dextran+ cells per image were determined and an average of all the images
analyzed/animal was reported as a percentage. Results show that there were no
differences in the percentage of pHrodo + cells within the dextran+ MZM population in
young and old (Fig. 37B) (n = 9 young and n = 9 old, p = 0.9456). From these results, I
conclude that the pHrodo +dextran+ MZM evaluated for phagocytosis in old were from a
pool of functional MZM and were a true representation of the old MZM population.
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Figure 37. The percentage of pHrodo+ cells of the dextran+ MZM. (A) Confocal
images taken live of young (left) and old (right) adherent splenocytes isolated from mice
given i.v. delivery of dextran-FITC. Splenocytes were harvested and given100 µg
pHrodo for 1.5 hr incubated at 37 C. Cells were imaged live at 5000x magnification at
cell thickness of 1 micron. The total number of pHrodo+ cells in a single image was
quantified over the total number of dextran+ MZM. (B) The ratio of pHrodo + cells:
dextran+ MZM/field determined and presented as a percentage. Results are expressed as
mean ± SEM and are representative of six separate experiments n = 9 young mice (2-3
mo); n = 9 old mice (19-23 mo). No significant differences present between young and
old mice. p = 0.9456, Unpaired t-test.
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Comparison of dextran-FITC phagocytized by MZM from young and old mice in
vivo as revealed by confocal microscopy
Tissue sections of spleens revealed that there was reduced dextran-FITC localized
on the MZM of old mice when compared to young mice (Fig. 26) and prior data also
revealed that there are decreases in the MZM pool with age. Perhaps the reason for
reduced MZM capture of dextran-FITC in old mice is a result of less MZM present in old
tissue and not a predictor of decreases in the phagocytic function of MZM with age.
Initially, the percentage of dextran+ MZM from young and old mice was quantified using
flow cytometry techniques (Fig. 27). Results showed a high level of background in the
control groups suggesting that the use of flow cytometry is limiting to determine
differences in MZM function.
Although cellular fluorescence prevented an accurate assessment of the quantity
of dextran bound by MZM by flow cytometry, dextran+ MZM could be visualized
live/cell at 5000x magnification under confocal microscopy without interference of
background fluorescence. The MFI of dextran-FITC in young and old MZM was
measured using confocal microscopy and image analysis. Images of pHrodo+ dextran+
MZM previously captured for measurement of pHrodo phagocytosis were again used to
determine the differences in phagocytosis of dextran between young and old MZM. Prior
data by Geijtenbeek et al. have reported that after initial dextran capture (observed in 45
min), MZM will phagocytosis dextran (17). Results showed that there were no
differences in the phagocytosis of dextran by MZM between age groups (Fig. 38). This
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data again shows that there are no functional differences between MZM from young and
old mice.
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Figure 38. Quantification of dextran-FITC in MZM from young and old mice as
revealed by confocal microscopy. Comparison of the MFI of dextran captured by MZM
from young and old mice. Using ImageJ software areas was drawn around the perimeter
of MZM and the MFI of dextran-FITC was determined. (A) Raw data gathered from
two separate experiments. Each point corresponds to the MFI of dextran captured by
MZM (B) Data are presented as a ratio of the sample MFI over the average MFI of young
per experimental group. p = 0.4256, Mann Whitney test. Data are expressed as mean ±
SEM and are representative of six separate experiments n = 9 young mice (2-3 mo); n = 9
old mice (19-23 mo).
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Summary of the functional studies on MZM
In order to determine the functional differences of MZM of young and old mice
these rare macrophages needed to be targeted. Currently there are no studies that have
reported the ability to isolate MZM without severe manipulation to the cell. Here I have
shown that MZM can be marked and its functional properties can be assessed. Initial
studies presented aimed to determine functional differences by the capture of dextranFITC upon i.v. injection. Results showed reduced dextran-FITC localized in MZM of
tissue sections of old mice when compared to young mice. However, I was not able to
quantify the amount of dextran-FITC capture. Using this experimental paradigm to mark
MZM I was able to target MZM while preserving cell viability. Once MZM were
targeted pHrodo was administered in order to determine differences in phagocytosis of
MZM from young and old mice. Results revealed that there were no differences in
phagocytosis between age groups. Therefore, the reduced dextran-FITC observed in
tissue sections of old mice are a result of fewer MZM present in old mice and not a result
of reduced cellular function.
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CHAPTER VII
DISCUSSION
The MZ of the spleen is known to be the site where blood-borne antigens first
enter the spleen at the porous MZ sinus. In this dissertation, the age-related changes in
the overall architecture of the MZ compartment were described. Specific reductions in
MZM and MZ B cells were observed. The MZ of young adult mice have a characteristic
uniform dense appearance around the white pulp and follicles; in contrast, the MZ of old
mice have a statistically significant cellular disruption when compared to young mice.
Alterations to the MZ included 1) reduction in abundance of MZM with no differences in
the phagocytic function of MZM, 2) a reduction in the frequency of MZ B cells that
correlated with the reductions observed with MZM, and 3) unusual staining patterns for
MAdCAM-1 sinus lining cells and MMM that may indicate positional changes.
Collectively, work from this dissertation showed that with advanced age there is a gross
anatomical breakdown of the MZ with decreases particularly striking in the MZM and
MZ B cell populations. Therefore, if the spleen architecture in humans suffers a similar
decline with advanced age, one consequence may be less efficient clearing and response
to bacteria, as has been reported in splenectomized and asplenic patients (112).
In humans, the MZ of the spleen is a clearly defined zone that is divided into
outer and inner parts by fibroblasts that are MAdCAM-1+ (112, 113). The MZ sinus is
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not present as a component of the human MZ and lymphocytes and antigens enter the
spleen via the splenic open circulation into the outer MZ area. This outer MZ area is
referred to as the perifollicular zone. The perifollicular zone of the human spleen
contains MZ B cells and sialoadhesin-positive macrophages, postulated to be the “human
equivalent” of MMM and MZM (113). Although differences in microanatomy are
present within the rodent and human splenic MZ areas, the human spleen is also
important in the immune response to infection with S. pneumoniae and its importance can
best be seen in epidemiological reports of splenectomized patients. A study showed a 5%
lifetime risk of “overwhelming infection syndrome” in these patients, which is lethal in
almost 50% (114). Studies have shown that when sepsis occurred in postsplenectomized
patients, in 80-90% of reported cases it resulted due to infection with S. pneumoniae
(115). S. pneumoniae are gram-positive bacteria that have a cell wall whose degradation
is achieved through phagocytosis (116). Antibody and complement coated S.
pneumoniae are believed to filter to the human spleen for removal. The phagocytes
present in the human splenic MZ are the sialoadhesin-positive macrophages; therefore,
future studies can examine these cells to determine if they are the primary phagocytes
involved in the removal of S. pneumoniae.
Functional abnormalities of the human spleen have been reported in the elderly
population. A condition termed hyposplenism in which the spleen has reduced function
has been reported in the elderly and in newborn infants (117). Patients with
hyposplenism have a reported increased mortality rate as a result of pneumococcal sepsis
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(118). Studies have also shown that vaccines that utilize T cell dependent mechanisms
are more effective in the prevention of pneumococcal disease in hyposplenic and asplenic
patients. Therefore, I believe that the elderly population would too benefit from T cell
dependent vaccines.
Alteration in the structure of the splenic marginal zone
At the MZ region of the spleen there is continuous migration of lymphocytes, self
antigens, and blood borne pathogens (7, 30, 82). The MZ can be seen as a major
intersection for the homing of lymphocytes to their respective zones and the sorting
station for TI and TD pathogens. Therefore, the positioning of the cellular components
that make up this MZ region can be seen as critical in its maintenance. The structure of
the MZ is highly ordered in young mice, with definitive boundaries at the white pulp and
red pulp regions. Examination of H&E tissue sections of young spleens revealed MZ
regions with minimal interface distortion and percent radius involvement. However, the
MZ regions of old mice were significantly more disrupted with a high degree of
variability. In many old mice, the interface distortion and percent radius involvement
was severe; however, in ~20 % of old mice the MZ regions appeared young-like in
morphology. What factors could contribute to this young-like morphology, given that
these old mice are inbred? An environmental stimulus is one answer. The mice in my
studies were housed 4 to a cage, and it is possible that natural dominance leads to chronic
stress contributing to the rapid aging of the submissive mice. Studies have shown that
chronic social defeat as a result of exposure to an aggressor mouse each day for 10 min
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for a total of 10 days leads to chronic stress (119). Chronic stress has been shown to be
accompanied by chromatin remodeling of the brain-derived neurotrophic factor gene
(BDNF), which has been shown to be important for the hippocampus to deal with stress
(120, 121). It may be possible that chronic social defeat may also contribute to damage
of immune system cells. The alteration in the morphology of the MZ in old mice
appeared to be due to an alteration of the cellular components that make up this zone.
The next sections will go through the cells that exhibited an alteration in age.
Decreases in marginal zone macrophages in old mice
Decreases in MZM in old mice were seen both semi-qualitatively (in tissue
sections) and quantitatively (via flow cytometry). An age related decrease in MZM may
have consequences on the immunity of aged individuals. For example, pneumonia
caused by S. pneumoniae is one of the leading causes of mortality in advanced age (2, 3).
SIGN-R1 [the murine homologue of human DC-SIGN (16)] on MZM binds the capsular
polysaccharide of S. pneumoniae (19, 20). It is possible that a decrease in the SIGN-R1+
MZM pool may allow for increased susceptibility to S. pneumoniae reported in the
elderly. Very little is known about the homeostasis of the MZM compartment. Three
possible mechanisms may contribute to the reductions in MZM with advanced age
include: decreased MZ B cells, decreased chemotactic factors important for MZM
homing to the MZ, or decreased MZM turnover.
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Evidence supports the first mechanism since decreases in MZ B cells in old mice,
when present, correlate with decreases in MZM (Fig. 14). In addition, a report by Kraal
et al. observed that recovery of MZM correlated with full restoration of the B cell
population in the MZ of mice after in vivo liposome treatment that led to depletion of all
splenic macrophages and most MZ B cells (39). Furthermore, it is important to point out
that although there was a significant decrease in MZM in old mice when compared to
young mice, there were approximately ~20% of old mice that had young like MZM
distributions in tissue and as revealed by flow cytometry. Data that revealed a
correlation between MZM and MZ B cells also showed that there are three separate
groups of MZM and MZ B correlates: one group having poor amounts of both cells, a
second group having moderate amounts of both cells, and a third group having
good/young-like amounts of MZM and MZ B cells. This separation is particularly
meaningfully because perhaps it reflects a gradual loss of the “young-like” phenotype in
old mice. It is possible that at some point all mice will have a loss of both cell
populations. Nolte et al. reported that overexpression of CD70 (a TNF family member)
specifically in B cells led to a gradual loss of the splenic B cell pool with a subsequent
gradual loss of MZM (40). In advanced age, this same phenomenon of a gradual loss
may occur and is represented by the moderate group seen here.
It is reasonable to propose that decreases in MZM with age can be influenced by
chemotactic factors important for MZM homing to the MZ. The chemokine CCL21
(protein) (Fig. 19A) was found in lesser amounts in the PALS region of old mice when
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compared to young mice. In addition, I determined that there was no co-localization of
CCL21 with MZM, rather CCL21 when present was localized outside the MZ, as
revealed by confocal microscopy (Fig. 20B). Preliminary observations also showed that
in some mice that have poor levels of MARCO+ MZM also have an abundance of CCL21
proteins in splenic tissue (Fig. 20C). It may be possible that in these mice there is an over
production of CCL21 in order to attract precursor MZM (if present) to the MZ to refill
the reduced MZM population. Whether this loss is due to the inability of newly made
MZM to home to the MZ or a result of loss of the resident MZM remains to be clear. It
has yet to be established if MZM are continuously made throughout the lifetime of the
animal or if the MZM observed 10 days post birth are maintained throughout a lifetime.
If the former is true, then MZM are continuously made every few days, weeks, or
months. It is possible in this scenario that the MZM of old mice may have a slower
turnover. Kraal et al. showed that new MZM will replenish a macrophage-depleted
young spleen by 30 days, implying that MZM precursors exist in young animals (39).
Therefore, it is possible that with advancement in age there is a decrease in MZM
replenishment and/or precursors that is responsible for the age related decrease in MZM.
Decreases in marginal zone B cells in old mice
The decrease in MZ B cell frequency in old mice is puzzling because an agerelated increase toward maintenance of existing MZ B cells has been predicted by
Allman and Miller (67). Moreover, certain conditions in old mice are more aligned with
MZ B cell development than follicular (FO) B cell development, such as low levels of
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E2A and IL-7 [reviewed in (11, 67, 68, 122) (69, 70, 75-77)]. A shift towards expanded
MZ B cell differentiation at the expense of FO B cell production was age is an attractive
hypothesis, and as previously mentioned in the background section of this dissertation,
increases in MZ B cell numbers were reported by one group using aged B10.D2 mice
(78). Furthermore, it may be possible that MZ B cells are being produced at expanded
levels in age; however, because of the collapse in the MZ micro-architecture in age, the
newly formed MZ B cells may not home effectively to the aged MZ compartment.
Adoptive transfer experiments presented in this dissertation (Chapter five) showed that
donor MZ B cells from young mice had a decreased ability to home to spleens of old
mice when compared to young mice. Moreover, when other lymphoid organs were
examined a MZ B cell phenotype was observed in both the lymph nodes and bone
marrow of a very few old mice (Table V). Experiments by Cariappa et al. have shown a
subset of recirculating mature B cells in the bone marrow able to respond to TI antigens
(123). It may be possible that these recirculating B cells that were identified were in fact
MZ B cells that were displaced to the bone marrow. Data from adoptive transfer
experiment suggests that the microenvironment of old mice is altered preventing homing
of MZ B cells. Another consideration is suggested by recent studies that have shown that
MZ B cells are lost during chronic inflammation (124, 125). Traggiai et al. report
changes in B-lineage subpopulations that appear similar to those reported in old mice (88,
89, 124). Chronic inflammation has been viewed by many investigators as part of
immunosenescence [reviewed in (98, 101)], raising the possibility that increased
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inflammation with age promotes gradual loss of MZ B cells, and perhaps, subsequent
decline of MZM. Lastly, it may also be that donor MZ B cells were not able to home to
the spleens of old mice because of the decreases in the MZM pool with age.
Yet, there are other factors important for the maintenance of MZ B cells to the
MZ. Reports by Cinamon et al. have demonstrated that S1P1 is needed for MZ B cells to
maintain localization in the MZ (64, 65), and reduction in receptor expression causes MZ
B cells to leave the MZ and move into the follicle in a CXCL13-dependent manner. If
decreases in S1P or its receptors are present in spleens of old mice, a displacement of MZ
B cells would be expected, perhaps not only to the follicular area, since CXCL13
expression has been shown to be disrupted with age (27), but near the MAdCAM1+ sinus
lining cells at the boundary of the MZ and white pulp interface where CXCL13 is
localized with age. Furthermore, recent work has shown that B cells from SHEP1deficient mice have a reduction in mature MZ B cells and fail to migrate towards
CXCL13 and S1P (126). Therefore, it may also be possible that there is an alteration in
the SHEP1 with age. SHEP1 is an adaptor molecule shown to partner with the
scaffolding protein CasL (important for integrin activation), which leads to the
phosphorylation of the serine/threonine of CasL allowing for MZ B cell retainment to the
MZ.
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The marginal zone sinus and metallophilic macrophages in old mice
The marginal zones in old mice also showed alterations in the MAdCAM-1+ MZ
sinus lining cells, which are part of the reticular family of cells (127, 128). Moreover,
these cells act as a “polarized” barrier to overt penetration of antigen from the MZ sinus
into the follicles; whereas, antigen readily moves from the sinus outward toward the
MZM and MZ B cell layer (64, 129). Results showed that the expression of MAdCAM-1
was diffused into the white pulp and less organized in old mice when compared to young
mice, and MMM were found to be similarly disrupted in old when compared to young
spleens. Changes in the morphology of MAdCAM-1+ and MMM compartments
appeared consistently disrupted in the majority of spleens from old mice. Strikingly
similar morphological disruptions in the MAdCAM-1+ sinus lining cells and MMM were
observed by Girkontaite et al. in sphingosine-1-phosphate receptor 3 (S1P3) deficient
mice (84). S1P3 is necessary for the positioning of MAdCAM-1+ sinus lining cells and
MMM along the continuity of the MZ sinus (84). It is possible that in old mice there is a
downregulation of S1P3, which is responsible for the morphological disruptions of the
MZ sinus and MMM. Furthermore, in the MZ compartment, S1P 1 and S1P3 are highly
expressed on MZ B cells and FO B cells (65). Therefore, it is possible that S1P and/or its
receptors provide a link between reduced MZM/MZ B cells and dispositioning of
MAdCAM-1+ cells/MMM (Fig. 8). S1P has also been implicated in the induction of
proteins found in junctional complexes, and at least one receptor (S1P1) was found on the
surface of reticular stromal cells, as well as endothelial cells, in lymph nodes (130).
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Recently, Katakai et al. provided evidence that the MAdCAM-1+ sinus lining cells derive
from a type of reticular stromal cell that requires constant LTβR stimulation for survival
and production of CXCL13 (128). These observations, along with the previous finding
that MZ sinus lining cells of aged spleens had less CXCL13 (27) could indicate a
problem in LTβR stimulation. It is also possible that either S1P and its receptors or
LT/LTβR provide a link between reduced MZM/MZ B cells and dispositioning of
MAdCAM-1+ cells.
No difference in marginal zone macrophage function in old mice
To determine whether reduced MZM affected antigen clearance in the MZ,
fluorescently labeled polysaccharide dextran that is known to bind SIGN-R1 (17, 18),
was administered via tail vein into both young and old mice. Less bound dextran in the
MZ of old mice was found when compared to young mice as revealed by confocal
microscopy (Chapter VI). Less bound dextran in old tissue sections could be a result of
fewer MZM available to bind blood-borne dextran. To answer this question, an approach
was needed to specifically identify MZM in order to measure functional differences in
age. MZM comprise 1-2% of the total splenic population and prior studies have had
limited success in isolating these cells for functional analysis ex vivo. Using a novel
approach, I was able to target MZM of young and old mice and administer pHrodo to
measure differences in phagocytosis of live cells using a Leica TCS SP5 confocal
microscope. Results showed that the phagocytic function of individual MZM was not
different between young and old mice, suggesting that it is this loss in the MZM
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population with age that contributes to the reduction in pathogen clearance reported in the
elderly.
Chronic inflammation in age
It is believed that in aging there is a low level of chronic inflammation as a result
of underlying disease a phenomenon termed “Inflam-aging” (101). It is believed that
chronic inflammation produces a heightened proinflammatory state. “Inflam-aging” is
characterized by a decrease in adaptive immunity and an increase in innate immunity. It
has been suggested that cells of the mononuclear phagocyte cell lineage are responsible
for the increase production of proinflammatory cytokines in age. Recently, Di Paolo et
al. showed that macrophages in the MZ trapped blood-borne adenovirus and rapidly
produced an IL-1α dependent pro-inflammatory response (131). It is conceivable that a
lifetime of repeated exposure and uptake of viruses and bacteria causes repeated
production of pro-inflammatory cytokines and chemokines, leading to overall damage to
the microenvironment and decrease in immune cells (Fig. 39). Yet, whether a hyperproinflammatory state or repeated exposure to viruses and bacteria can lead to a
hindrance in normal cell frequencies and function still remains to be elucidated for
immune cells.
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Figure 39. Model of the Microenvironmental alterations of the Splenic Marginal
Zone. Factors that may contribute to decreases in the cellular components of the MZ.
(1) There is a correlation between decreases in MZM and MZ B cells in old mice.
Decreases in MZM can be a result of decreases in MZ B cells. Furthermore, it may be
possible that the chemokine CCL21 is over produced in the spleens of old mice to home
precursor MZM to MZ that have a reduction in MZM. On the contrary, decreases in MZ
B cells may be due to decreases in MZM or downregulation of S1P 3. (2) MAdCAM1+
MZ sinus lining cells are observed in multiple cell layers and MMM are not continuous
with the MZ sinus. This alteration may also be due to a reduction in S1P 3. (3) MZ B
cells may also exit the spleen and home to the bone marrow or the lymph nodes. (4) It is
also possible that as a result of “Inflam-aging” there is an over production of
proinflammatory cytokines such as TNFα leading to damage and loss of the MZ cells.
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Significance
Understanding the alterations that occur with age in lymphoid tissues such as the
spleen is important for developing more efficient therapies for the prevention of diseases
such as bacterial pneumonia that have shown to be highly detrimental in the elderly (2).
The cells that contribute to framework of the MZ of the spleen are largely responsible for
initiating an effective immune response to the vaccine components for the prevention of
S. pneumoniae and other TI antigens. The goal of this study was to determine if there
were age-related changes in the cellular components of the MZ in old versus young mice.
Results show changes throughout the components of the MZ, including the: MZ sinus
lining cells, MMM, MZM, and MZ B cells. Furthermore, reductions in MZM in
individual old mice correlated with reductions in MZ B cell populations with some of the
old mice exhibiting young-like MZM and MZ B cell phenotypes. Future studies can
examine old mice in order to determine what attributes to these young-like phenotypes,
and perhaps insights gained from these studies can pave the way for a modern day
fountain-of-youth. In terms of vaccine efficacy, vaccines can target the deficient MZM
and MZ B cell populations in aging individuals to heighten the immune response against
the TI components that constitute current vaccines.
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